{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T06:12:39Z","timestamp":1794550359871,"version":"4.9.1"},"reference-count":341,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T00:00:00Z","timestamp":1782259200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100020265","name":"Stan Perron Charitable Foundation","doi-asserted-by":"publisher","award":["202003028"],"award-info":[{"award-number":["202003028"]}],"id":[{"id":"10.13039\/501100020265","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","surveyophthalmol.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Survey of Ophthalmology"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.survophthal.2026.06.009","type":"journal-article","created":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T16:29:05Z","timestamp":1781800145000},"page":"1558-1590","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Predicting the progression of proliferative diabetic retinopathy: Pathophysiology, imaging phenotypes, and determinants of disease persistence despite therapy"],"prefix":"10.1016","volume":"71","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-4492-4394","authenticated-orcid":false,"given":"Brendan","family":"Luu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elon H.C.","family":"van Dijk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Hein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong","family":"An","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dao-Yi","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chandrakumar","family":"Balaratnasingam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.survophthal.2026.06.009_bib1","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1016\/j.ophtha.2021.04.027","article-title":"Global Prevalence of Diabetic Retinopathy and Projection of Burden through 2045: Systematic Review and Meta-analysis","volume":"128","author":"Teo","year":"2021","journal-title":"Ophthalmology"},{"issue":"7","key":"10.1016\/j.survophthal.2026.06.009_bib2","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/j.ophtha.2025.01.022","article-title":"Twenty-year trends in prevalence and incidence of diabetic retinal disease","volume":"132","author":"VanderBeek","year":"2025","journal-title":"Ophthalmology"},{"key":"10.1016\/j.survophthal.2026.06.009_bib3","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.preteyeres.2015.08.001","article-title":"The progress in understanding and treatment of diabetic retinopathy","volume":"51","author":"Stitt","year":"2016","journal-title":"Prog Retin Eye Res"},{"key":"10.1016\/j.survophthal.2026.06.009_bib4","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.3389\/fcell.2022.963615","article-title":"The pathophysiological mechanisms underlying diabetic retinopathy","volume":"10","author":"Wei","year":"2022","journal-title":"Front Cell Dev Biol"},{"issue":"5","key":"10.1016\/j.survophthal.2026.06.009_bib5","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.preteyeres.2011.05.002","article-title":"Inflammation in diabetic retinopathy","volume":"30","author":"Tang","year":"2011","journal-title":"Prog Retin Eye Res"},{"issue":"5, Supplement","key":"10.1016\/j.survophthal.2026.06.009_bib6","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/S0161-6420(13)38011-7","article-title":"Early Photocoagulation for Diabetic Retinopathy: ETDRS Report Number 9","volume":"98","author":"Early Treatment Diabetic Retinopathy Study Research Group.","year":"1991","journal-title":"Ophthalmology"},{"issue":"7","key":"10.1016\/j.survophthal.2026.06.009_bib7","first-page":"583","article-title":"Photocoagulation treatment of proliferative diabetic retinopathy. Clinical application of Diabetic Retinopathy Study (DRS) findings, DRS Report Number 8","volume":"88","author":"The Diabetic Retinopathy Study Research Group.","year":"1981","journal-title":"Ophthalmology"},{"issue":"2","key":"10.1016\/j.survophthal.2026.06.009_bib8","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1097\/IIO.0000000000000027","article-title":"Current management of vitreous hemorrhage due to proliferative diabetic retinopathy","volume":"54","author":"El Annan","year":"2014","journal-title":"Int Ophthalmol Clin"},{"issue":"5","key":"10.1016\/j.survophthal.2026.06.009_bib9","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.ophtha.2017.12.008","article-title":"Ranibizumab Plus Panretinal Photocoagulation versus Panretinal Photocoagulation Alone for High-Risk Proliferative Diabetic Retinopathy (PROTEUS Study)","volume":"125","author":"Figueira","year":"2018","journal-title":"Ophthalmology"},{"issue":"5","key":"10.1016\/j.survophthal.2026.06.009_bib10","doi-asserted-by":"crossref","first-page":"e530","DOI":"10.1111\/aos.14312","article-title":"Efficacy and safety of ranibizumab with or without panretinal laser photocoagulation versus laser photocoagulation alone in proliferative diabetic retinopathy \u2013 the PRIDE study","volume":"98","author":"Lang","year":"2020","journal-title":"Acta Ophthalmol"},{"issue":"20","key":"10.1016\/j.survophthal.2026.06.009_bib11","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1001\/jama.2015.15217","article-title":"Network WCftDRCR. Panretinal Photocoagulation vs Intravitreous Ranibizumab for Proliferative Diabetic Retinopathy: A Randomized Clinical Trial","volume":"314","year":"2015","journal-title":"JAMA"},{"issue":"10085","key":"10.1016\/j.survophthal.2026.06.009_bib12","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1016\/S0140-6736(17)31193-5","volume":"389","author":"Sivaprasad","year":"2017","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.survophthal.2026.06.009_bib13","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-93384-5","article-title":"Risk factors associated with progression of diabetic retinopathy in eyes treated with panretinal photocoagulation","volume":"11","author":"Baek","year":"2021","journal-title":"Sci Rep"},{"issue":"4","key":"10.1016\/j.survophthal.2026.06.009_bib14","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.ophtha.2016.12.005","article-title":"Factors Associated with Worsening Proliferative Diabetic Retinopathy in Eyes Treated with Panretinal Photocoagulation or Ranibizumab","volume":"124","author":"Bressler","year":"2017","journal-title":"Ophthalmology"},{"issue":"10","key":"10.1016\/j.survophthal.2026.06.009_bib15","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1001\/jamaophthalmol.2018.3255","article-title":"Five-Year Outcomes of Panretinal Photocoagulation vs Intravitreous Ranibizumab for Proliferative Diabetic Retinopathy: A Randomized Clinical Trial","volume":"136","author":"Gross","year":"2018","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.survophthal.2026.06.009_bib16","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1016\/S0161-6420(13)38012-9","article-title":"Grading diabetic retinopathy from stereoscopic color fundus photographs--an extension of the modified Airlie House classification. ETDRS report number 10","volume":"98","author":"Early Treatment Diabetic Retinopathy Study Research Group.","year":"1991","journal-title":"Ophthalmology"},{"issue":"9","key":"10.1016\/j.survophthal.2026.06.009_bib17","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1016\/S0161-6420(03)00475-5","article-title":"Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales","volume":"110","author":"Wilkinson","year":"2003","journal-title":"Ophthalmology"},{"issue":"5","key":"10.1016\/j.survophthal.2026.06.009_bib18","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/S0161-6420(13)38014-2","article-title":"Fundus Photographic Risk Factors for Progression of Diabetic Retinopathy: ETDRS Report Number 12","volume":"98","author":"Early Treatment Diabetic Retinopathy Research Group.","year":"1991","journal-title":"Ophthalmology"},{"issue":"22","key":"10.1016\/j.survophthal.2026.06.009_bib19","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1056\/NEJM199412013312203","article-title":"Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders","volume":"331","author":"Aiello","year":"1994","journal-title":"N Engl J Med"},{"issue":"11","key":"10.1016\/j.survophthal.2026.06.009_bib20","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1016\/S0161-6420(96)30420-X","article-title":"Intravitreous injections of vascular endothelial growth factor produce retinal ischemia and microangiopathy in an adult primate","volume":"103","author":"Tolentino","year":"1996","journal-title":"Ophthalmology"},{"issue":"5","key":"10.1016\/j.survophthal.2026.06.009_bib21","article-title":"Update on the Management of Diabetic Retinopathy: Anti-VEGF Agents for the Prevention of Complications and Progression of Nonproliferative and Proliferative Retinopathy","volume":"13","author":"Bahr","year":"2023","journal-title":"Life (Basel)"},{"issue":"1","key":"10.1016\/j.survophthal.2026.06.009_bib22","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1186\/s12886-024-03491-w","article-title":"Impact of anti-VEGF treatment on development of proliferative diabetic retinopathy in routine clinical practice","volume":"24","author":"Moshfeghi","year":"2024","journal-title":"BMC Ophthalmol"},{"issue":"11","key":"10.1016\/j.survophthal.2026.06.009_bib23","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.18240\/ijo.2022.11.02","article-title":"Comprehensive assessment of growth factors, inflammatory mediators, and cytokines in vitreous from patients with proliferative diabetic retinopathy","volume":"15","author":"Gong","year":"2022","journal-title":"Int J Ophthalmol"},{"issue":"2","key":"10.1016\/j.survophthal.2026.06.009_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.xops.2025.101003","article-title":"Inflammatory Mediators in the PathophysIology of Diabetic Retinopathy Study: Baseline Analysis of 24 Aqueous Cytokines","volume":"6","author":"Kim","year":"2026","journal-title":"Ophthalmol Sci"},{"issue":"5","key":"10.1016\/j.survophthal.2026.06.009_bib25","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1007\/s00125-007-0621-4","article-title":"Advanced glycation end products cause increased CCN family and extracellular matrix gene expression in the diabetic rodent retina","volume":"50","author":"Hughes","year":"2007","journal-title":"Diabetologia"},{"key":"10.1016\/j.survophthal.2026.06.009_bib26","doi-asserted-by":"crossref","first-page":"43603","DOI":"10.1155\/2007\/43603","article-title":"Oxidative stress and diabetic retinopathy","volume":"2007","author":"Kowluru","year":"2007","journal-title":"Exp Diabetes Res"},{"key":"10.1016\/j.survophthal.2026.06.009_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.preteyeres.2022.101134","article-title":"Studies of the retinal microcirculation using human donor eyes and high-resolution clinical imaging: Insights gained to guide future research in diabetic retinopathy","volume":"94","author":"Balaratnasingam","year":"2023","journal-title":"Prog Retin Eye Res"},{"issue":"6","key":"10.1016\/j.survophthal.2026.06.009_bib28","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.exer.2005.01.018","article-title":"Retinal degeneration and local oxygen metabolism","volume":"80","author":"Yu","year":"2005","journal-title":"Exp Eye Res"},{"issue":"11","key":"10.1016\/j.survophthal.2026.06.009_bib29","doi-asserted-by":"crossref","first-page":"3035","DOI":"10.4103\/ijo.IJO_1326_21","article-title":"Inflammatory mediators in diabetic retinopathy: Deriving clinicopathological correlations for potential targeted therapy","volume":"69","author":"Sheemar","year":"2021","journal-title":"Indian J Ophthalmol"},{"issue":"12","key":"10.1016\/j.survophthal.2026.06.009_bib30","doi-asserted-by":"crossref","first-page":"2656","DOI":"10.1007\/s00125-010-1900-z","article-title":"Hyperglycaemia-induced pro-inflammatory responses by retinal M\u00fcller glia are regulated by the receptor for advanced glycation end-products (RAGE)","volume":"53","author":"Zong","year":"2010","journal-title":"Diabetologia"},{"issue":"4","key":"10.1016\/j.survophthal.2026.06.009_bib31","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/s11892-011-0204-0","article-title":"Microvascular modifications in diabetic retinopathy","volume":"11","author":"Durham","year":"2011","journal-title":"Curr Diab Rep"},{"issue":"12","key":"10.1016\/j.survophthal.2026.06.009_bib32","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1096\/fj.03-1476fje","article-title":"A central role for inflammation in the pathogenesis of diabetic retinopathy","volume":"18","author":"Joussen","year":"2004","journal-title":"Faseb J"},{"issue":"19","key":"10.1016\/j.survophthal.2026.06.009_bib33","doi-asserted-by":"crossref","first-page":"10836","DOI":"10.1073\/pnas.96.19.10836","article-title":"Prevention of leukostasis and vascular leakage in streptozotocin-induced diabetic retinopathy via intercellular adhesion molecule-1 inhibition","volume":"96","author":"Miyamoto","year":"1999","journal-title":"Proc Natl Acad Sci USA"},{"issue":"6","key":"10.1016\/j.survophthal.2026.06.009_bib34","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19061816","article-title":"Diabetic Retinopathy: Pathophysiology and Treatments","volume":"19","author":"Wang","year":"2018","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10.1016\/j.survophthal.2026.06.009_bib35","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1152\/physiolgenomics.00048.2006","article-title":"Angiopoietin-1 and vascular endothelial growth factor induce expression of inflammatory cytokines before angiogenesis","volume":"27","author":"Aplin","year":"2006","journal-title":"Physiol Genom"},{"issue":"7","key":"10.1016\/j.survophthal.2026.06.009_bib36","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1038\/nm884","article-title":"Role of PlGF in the intra- and intermolecular cross talk between the VEGF receptors Flt1 and Flk1","volume":"9","author":"Autiero","year":"2003","journal-title":"Nat Med"},{"issue":"8","key":"10.1016\/j.survophthal.2026.06.009_bib37","doi-asserted-by":"crossref","first-page":"3336","DOI":"10.1182\/blood.V87.8.3336.bloodjournal8783336","article-title":"Migration of human monocytes in response to vascular endothelial growth factor (VEGF) is mediated via the VEGF receptor flt-1","volume":"87","author":"Barleon","year":"1996","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.survophthal.2026.06.009_bib38","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-12683-7","article-title":"Effect of cytokine-induced alterations in extracellular matrix composition on diabetic retinopathy-relevant endothelial cell behaviors","volume":"12","author":"Giblin","year":"2022","journal-title":"Sci Rep"},{"key":"10.1016\/j.survophthal.2026.06.009_bib39","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.3389\/fendo.2020.00591","article-title":"Endothelial Dysfunction in Diabetic Retinopathy","volume":"11","author":"Gui","year":"2020","journal-title":"Front Endocrinol"},{"issue":"4","key":"10.1016\/j.survophthal.2026.06.009_bib40","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1182\/blood-2002-11-3422","article-title":"Placenta growth factor activates monocytes and correlates with sickle cell disease severity","volume":"102","author":"Perelman","year":"2003","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.survophthal.2026.06.009_bib41","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/s00417-004-0874-2","article-title":"Induction of IL-8, MCP-1, and bFGF by TNF-alpha in retinal glial cells: implications for retinal neovascularization during post-ischemic inflammation","volume":"242","author":"Yoshida","year":"2004","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.survophthal.2026.06.009_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2021.155774","article-title":"Inflammatory cytokines and retinal nonperfusion area in quiescent proliferative diabetic retinopathy","volume":"154","author":"Lee","year":"2022","journal-title":"Cytokine"},{"key":"10.1016\/j.survophthal.2026.06.009_bib43","doi-asserted-by":"crossref","DOI":"10.1038\/s41433-022-02127-x","article-title":"Changes in aqueous and vitreous inflammatory cytokine levels in proliferative diabetic retinopathy: a systematic review and meta-analysis","author":"Mason","year":"2022","journal-title":"Eye"},{"key":"10.1016\/j.survophthal.2026.06.009_bib44","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/424783","article-title":"The Measurement of Intraocular Biomarkers in Various Stages of Proliferative Diabetic Retinopathy Using Multiplex xMAP Technology","volume":"2015","author":"Rusnak","year":"2015","journal-title":"J Ophthalmol"},{"issue":"1","key":"10.1016\/j.survophthal.2026.06.009_bib45","doi-asserted-by":"crossref","first-page":"71","DOI":"10.2174\/157339906775473671","article-title":"Angiogenic and antiangiogenic factors in proliferative diabetic retinopathy","volume":"2","author":"Sim\u00f3","year":"2006","journal-title":"Curr Diabetes Rev"},{"issue":"10","key":"10.1016\/j.survophthal.2026.06.009_bib46","doi-asserted-by":"crossref","first-page":"3107","DOI":"10.2337\/diabetes.51.10.3107","article-title":"Pericytes and the pathogenesis of diabetic retinopathy","volume":"51","author":"Hammes","year":"2002","journal-title":"Diabetes"},{"key":"10.1016\/j.survophthal.2026.06.009_bib47","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.cytogfr.2017.11.005","article-title":"Vascular endothelial growth factors and placenta growth factor in retinal vasculopathies: Current research and future perspectives","volume":"39","author":"Mesquita","year":"2018","journal-title":"Cytokine Growth Factor Rev"},{"issue":"5","key":"10.1016\/j.survophthal.2026.06.009_bib48","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1038\/eye.2014.13","article-title":"A review of anti-VEGF agents for proliferative diabetic retinopathy","volume":"28","author":"Osaadon","year":"2014","journal-title":"Eye"},{"issue":"9","key":"10.1016\/j.survophthal.2026.06.009_bib49","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.4065\/81.9.1241","article-title":"Biology of Platelet-Derived Growth Factor and Its Involvement in Disease","volume":"81","author":"Alvarez","year":"2006","journal-title":"Mayo Clin Proc"},{"issue":"6","key":"10.1016\/j.survophthal.2026.06.009_bib50","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1001\/archopht.116.6.738","article-title":"S. Transforming growth factor beta2 in the vitreous in proliferative diabetic retinopathy","volume":"116","author":"Hirase","year":"1998","journal-title":"Arch Ophthalmol"},{"issue":"1","key":"10.1016\/j.survophthal.2026.06.009_bib51","first-page":"109","article-title":"Increased expression of placenta growth factor in proliferative diabetic retinopathy","volume":"78","author":"Khaliq","year":"1998","journal-title":"Lab Investig"},{"issue":"12","key":"10.1016\/j.survophthal.2026.06.009_bib52","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1038\/sj.onc.1204231","article-title":"Two distinct signalling pathways are involved in FGF2-stimulated proliferation of choriocapillary endothelial cells: a comparative study with VEGF","volume":"20","author":"Zubilewicz","year":"2001","journal-title":"Oncogene"},{"issue":"3","key":"10.1016\/j.survophthal.2026.06.009_bib53","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/s00109-013-0993-5","article-title":"Ocular neovascularization","volume":"91","author":"Campochiaro","year":"2013","journal-title":"J Mol Med (Berl)"},{"issue":"2","key":"10.1016\/j.survophthal.2026.06.009_bib54","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1002\/biof.30","article-title":"Connective tissue growth factor: Context-dependent functions and mechanisms of regulation","volume":"35","author":"Cicha","year":"2009","journal-title":"BioFactors"},{"issue":"11","key":"10.1016\/j.survophthal.2026.06.009_bib55","doi-asserted-by":"crossref","first-page":"2446","DOI":"10.1016\/j.ajpath.2018.07.016","article-title":"Heparin-Binding Epidermal Growth Factor-Like Growth Factor as a Critical Mediator of Tissue Repair and Regeneration","volume":"188","author":"Dao","year":"2018","journal-title":"Am J Pathol"},{"issue":"4","key":"10.1016\/j.survophthal.2026.06.009_bib56","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.cytogfr.2004.03.007","article-title":"The PDGF family: four gene products form five dimeric isoforms","volume":"15","author":"Fredriksson","year":"2004","journal-title":"Cytokine Growth Factor Rev"},{"issue":"6","key":"10.1016\/j.survophthal.2026.06.009_bib57","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/S1350-9462(00)00015-X","article-title":"Hepatocyte growth factor\/scatter factor in the eye","volume":"19","author":"Grierson","year":"2000","journal-title":"Prog Retin Eye Res"},{"issue":"34","key":"10.1016\/j.survophthal.2026.06.009_bib58","doi-asserted-by":"crossref","first-page":"22961","DOI":"10.1074\/jbc.M109.014787","article-title":"Increased intraocular insulin-like growth factor-I triggers blood-retinal barrier breakdown","volume":"284","author":"Haurigot","year":"2009","journal-title":"J Biol Chem"},{"issue":"4","key":"10.1016\/j.survophthal.2026.06.009_bib59","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1002\/jcb.240520406","article-title":"Endothelial cells exhibiting angiogenesis in vitro proliferate in response to TGF-beta 1","volume":"52","author":"Iruela-Arispe","year":"1993","journal-title":"J Cell Biochem"},{"issue":"20","key":"10.1016\/j.survophthal.2026.06.009_bib60","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.2174\/138161207781039689","article-title":"Fibroblast growth factors\/fibroblast growth factor receptors as targets for the development of anti-angiogenesis strategies","volume":"13","author":"Rusnati","year":"2007","journal-title":"Curr Pharm Des"},{"issue":"5","key":"10.1016\/j.survophthal.2026.06.009_bib61","first-page":"469","article-title":"Differential roles of vascular endothelial growth factor receptor-1 and receptor-2 in angiogenesis","volume":"39","author":"Shibuya","year":"2006","journal-title":"J Biochem Mol Biol"},{"issue":"11","key":"10.1016\/j.survophthal.2026.06.009_bib62","doi-asserted-by":"crossref","DOI":"10.3390\/biom13111630","article-title":"Vitreous Levels of Vascular Endothelial Growth Factor and Platelet-Derived Growth Factor in Patients with Proliferative Diabetic Retinopathy: A Clinical Correlation","volume":"13","author":"Al-Dwairi","year":"2023","journal-title":"Biomolecules"},{"issue":"24","key":"10.1016\/j.survophthal.2026.06.009_bib63","article-title":"TGF-\u03b2 Serum Levels in Diabetic Retinopathy Patients and the Role of Anti-VEGF Therapy","volume":"21","author":"Bonfiglio","year":"2020","journal-title":"Int J Mol Sci [Internet]"},{"issue":"1","key":"10.1016\/j.survophthal.2026.06.009_bib64","doi-asserted-by":"crossref","first-page":"80","DOI":"10.2337\/diacare.23.1.80","article-title":"Vitreous levels of IGF-I, IGF binding protein 1, and IGF binding protein 3 in proliferative diabetic retinopathy: a case-control study","volume":"23","author":"Burgos","year":"2000","journal-title":"Diabetes Care"},{"issue":"7","key":"10.1016\/j.survophthal.2026.06.009_bib65","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1136\/bjo.84.7.732","article-title":"Hepatocyte growth factor in vitreous and serum from patients with proliferative diabetic retinopathy","volume":"84","author":"Cant\u00f3n","year":"2000","journal-title":"Br J Ophthalmol"},{"issue":"5","key":"10.1016\/j.survophthal.2026.06.009_bib66","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1076\/ceyr.23.5.368.5441","article-title":"Vitreous levels of insulin-like growth factor-I in patients with proliferative diabetic retinopathy","volume":"23","author":"Inokuchi","year":"2001","journal-title":"Curr Eye Res"},{"issue":"11","key":"10.1016\/j.survophthal.2026.06.009_bib67","doi-asserted-by":"crossref","first-page":"6523","DOI":"10.1167\/iovs.15-16793","article-title":"Angiogenic and Inflammatory Vitreous Biomarkers Associated With Increasing Levels of Retinal Ischemia","volume":"56","author":"Kovacs","year":"2015","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.survophthal.2026.06.009_bib68","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.2147\/OPTH.S248812","article-title":"Budu. Vitreous and serum concentrations of vascular endothelial growth factor and platelet-derived growth factor in proliferative diabetic retinopathy","volume":"14","author":"Muhiddin","year":"2020","journal-title":"Clin Ophthalmol"},{"issue":"6","key":"10.1016\/j.survophthal.2026.06.009_bib69","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1001\/archopht.1990.01070080113046","article-title":"Basic Fibroblast Growth Factor Levels in the Vitreous of Patients With Proliferative Diabetic Retinopathy","volume":"108","author":"Sivalingam","year":"1990","journal-title":"Arch Ophthalmol"},{"issue":"1","key":"10.1016\/j.survophthal.2026.06.009_bib70","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0280488","article-title":"Increased Angiopoietin-1 and -2 levels in human vitreous are associated with proliferative diabetic retinopathy","volume":"18","author":"Tsai","year":"2023","journal-title":"PLOS ONE"},{"issue":"1","key":"10.1016\/j.survophthal.2026.06.009_bib71","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1159\/000048324","article-title":"Non-paralleled increase of hepatocyte growth factor and vascular endothelial growth factor in the eyes with angiogenic and nonangiogenic fibroproliferation","volume":"34","author":"Umeda","year":"2002","journal-title":"Ophthalmic Res"},{"issue":"3","key":"10.1016\/j.survophthal.2026.06.009_bib72","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.ajo.2004.10.004","article-title":"Vitreous levels of angiopoietin 2 and vascular endothelial growth factor in patients with proliferative diabetic retinopathy","volume":"139","author":"Watanabe","year":"2005","journal-title":"Am J Ophthalmol"},{"issue":"18","key":"10.1016\/j.survophthal.2026.06.009_bib73","doi-asserted-by":"crossref","first-page":"11947","DOI":"10.1016\/S0021-9258(18)99049-6","article-title":"The human gene for vascular endothelial growth factor. Multiple protein forms are encoded through alternative exon splicing","volume":"266","author":"Tischer","year":"1991","journal-title":"J Biol Chem"},{"issue":"12","key":"10.1016\/j.survophthal.2026.06.009_bib74","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1091\/mbc.4.12.1317","article-title":"The vascular endothelial growth factor (VEGF) isoforms: differential deposition into the subepithelial extracellular matrix and bioactivity of extracellular matrix-bound VEGF","volume":"4","author":"Park","year":"1993","journal-title":"Mol Biol Cell"},{"issue":"5","key":"10.1016\/j.survophthal.2026.06.009_bib75","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1091\/mbc.e09-07-0590","article-title":"Binding to the extracellular matrix and proteolytic processing: two key mechanisms regulating vascular endothelial growth factor action","volume":"21","author":"Ferrara","year":"2010","journal-title":"Mol Biol Cell"},{"key":"10.1016\/j.survophthal.2026.06.009_bib76","doi-asserted-by":"crossref","DOI":"10.1016\/j.exer.2024.110062","article-title":"VEGF-A165a and angiopoietin-2 differently affect the barrier formed by retinal endothelial cells","volume":"247","author":"Deissler","year":"2024","journal-title":"Exp Eye Res"},{"issue":"17","key":"10.1016\/j.survophthal.2026.06.009_bib77","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1007\/s00018-006-6254-9","article-title":"A VEGF-A splice variant defective for heparan sulfate and neuropilin-1 binding shows attenuated signaling through VEGFR-2","volume":"63","author":"C\u00e9be Suarez","year":"2006","journal-title":"Cell Mol Life Sci"},{"issue":"8","key":"10.1016\/j.survophthal.2026.06.009_bib78","doi-asserted-by":"crossref","first-page":"4273","DOI":"10.1167\/iovs.09-4296","article-title":"VEGF-A165b Is Cytoprotective and Antiangiogenic in the Retina","volume":"51","author":"Magnussen","year":"2010","journal-title":"Invest Ophthalmol & Vis Sci"},{"issue":"12","key":"10.1016\/j.survophthal.2026.06.009_bib79","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1042\/CS20170102","article-title":"Vascular endothelial growth factor-A165b ameliorates outer-retinal barrier and vascular dysfunction in the diabetic retina","volume":"131","author":"Ved","year":"2017","journal-title":"Clin Sci"},{"issue":"4","key":"10.1016\/j.survophthal.2026.06.009_bib80","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.preteyeres.2008.05.001","article-title":"Vascular endothelial growth factor in eye disease","volume":"27","author":"Penn","year":"2008","journal-title":"Prog Retin Eye Res"},{"issue":"6","key":"10.1016\/j.survophthal.2026.06.009_bib81","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1016\/j.cell.2019.01.021","article-title":"VEGF in signaling and disease: beyond discovery and development","volume":"176","author":"Apte","year":"2019","journal-title":"Cell"},{"issue":"13","key":"10.1016\/j.survophthal.2026.06.009_bib82","first-page":"475","article-title":"Effect of VEGF and anti-vegf compounds on retinal pigment epithelium permeability: an in vitro study","volume":"51","author":"Campa","year":"2010","journal-title":"Invest Ophthalmol & Vis Sci"},{"issue":"1","key":"10.1016\/j.survophthal.2026.06.009_bib83","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-71484-y","article-title":"VEGF-A splice variants bind VEGFRs with differential affinities","volume":"10","author":"Mamer","year":"2020","journal-title":"Sci Rep"},{"issue":"7203","key":"10.1016\/j.survophthal.2026.06.009_bib84","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1038\/nature07205","article-title":"Cancer-related inflammation","volume":"454","author":"Mantovani","year":"2008","journal-title":"Nature"},{"issue":"12","key":"10.1016\/j.survophthal.2026.06.009_bib85","doi-asserted-by":"crossref","first-page":"2879","DOI":"10.1016\/j.febslet.2006.03.087","article-title":"Biology of vascular endothelial growth factors","volume":"580","author":"Roy","year":"2006","journal-title":"FEBS Lett"},{"issue":"41","key":"10.1016\/j.survophthal.2026.06.009_bib86","doi-asserted-by":"crossref","first-page":"25646","DOI":"10.1016\/S0021-9258(18)47298-5","article-title":"Placenta growth factor: Potentiation of vascular endothelial growth factor bioactivity, in vitro and in vivo, and high affinity binding to Flt-1 but not to Flk-1\/KDR","volume":"269","author":"Park","year":"1994","journal-title":"J Biol Chem"},{"issue":"8","key":"10.1016\/j.survophthal.2026.06.009_bib87","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1038\/nm731","article-title":"Revascularization of ischemic tissues by PlGF treatment, and inhibition of tumor angiogenesis, arthritis and atherosclerosis by anti-Flt1","volume":"8","author":"Luttun","year":"2002","journal-title":"Nat Med"},{"issue":"3","key":"10.1016\/j.survophthal.2026.06.009_bib88","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0017462","article-title":"Placental growth factor contributes to micro-vascular abnormalization and blood-retinal barrier breakdown in diabetic retinopathy","volume":"6","author":"Kowalczuk","year":"2011","journal-title":"PLoS ONE"},{"issue":"6","key":"10.1016\/j.survophthal.2026.06.009_bib89","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1076\/ceyr.18.6.490.5267","article-title":"Basement membrane and growth factor gene expression in normal and diabetic human retinas","volume":"18","author":"Spirin","year":"1999","journal-title":"Curr Eye Res"},{"issue":"3","key":"10.1016\/j.survophthal.2026.06.009_bib90","first-page":"372","article-title":"Expression of placenta growth factor (PIGF) in ischaemic retinal diseases","volume":"13","author":"Yamashita","year":"1999","journal-title":"Eye (Basingstoke)"},{"key":"10.1016\/j.survophthal.2026.06.009_bib91","first-page":"2022","article-title":"Mechanistic pathogenesis of endothelial dysfunction in diabetic nephropathy and retinopathy","volume":"13","author":"Yang","year":"2022","journal-title":"Front Endocrinol"},{"issue":"5323","key":"10.1016\/j.survophthal.2026.06.009_bib92","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1126\/science.277.5323.242","article-title":"Pericyte loss and microaneurysm formation in PDGF-B-deficient mice","volume":"277","author":"Lindahl","year":"1997","journal-title":"Science"},{"issue":"11","key":"10.1016\/j.survophthal.2026.06.009_bib93","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1038\/nm.2052","article-title":"Activation of PKC-delta and SHP-1 by hyperglycemia causes vascular cell apoptosis and diabetic retinopathy","volume":"15","author":"Geraldes","year":"2009","journal-title":"Nat Med"},{"issue":"7223","key":"10.1016\/j.survophthal.2026.06.009_bib94","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1038\/nature07424","article-title":"A role for VEGF as a negative regulator of pericyte function and vessel maturation","volume":"456","author":"Greenberg","year":"2008","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.survophthal.2026.06.009_bib95","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1038\/s41433-020-01377-x","article-title":"Angiopoietin\/Tie2 signalling and its role in retinal and choroidal vascular diseases: a review of preclinical data","volume":"35","author":"Joussen","year":"2021","journal-title":"Eye (Lond)"},{"issue":"11","key":"10.1016\/j.survophthal.2026.06.009_bib96","doi-asserted-by":"crossref","first-page":"4150","DOI":"10.1182\/blood-2003-10-3685","article-title":"The Tie-2 ligand angiopoietin-2 is stored in and rapidly released upon stimulation from endothelial cell Weibel-Palade bodies","volume":"103","author":"Fiedler","year":"2004","journal-title":"Blood"},{"issue":"5322","key":"10.1016\/j.survophthal.2026.06.009_bib97","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1126\/science.277.5322.55","article-title":"Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis","volume":"277","author":"Maisonpierre","year":"1997","journal-title":"Science"},{"issue":"6","key":"10.1016\/j.survophthal.2026.06.009_bib98","doi-asserted-by":"crossref","first-page":"3784","DOI":"10.1167\/iovs.10-6386","article-title":"A potential role for angiopoietin 2 in the regulation of the blood-retinal barrier in diabetic retinopathy","volume":"52","author":"Rangasamy","year":"2011","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"4","key":"10.1016\/j.survophthal.2026.06.009_bib99","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1006\/exer.2001.1161","article-title":"Effects of Angiogenic Growth Factor Combinations on Retinal Endothelial Cells","volume":"74","author":"Castellon","year":"2002","journal-title":"Exp Eye Res"},{"issue":"7","key":"10.1016\/j.survophthal.2026.06.009_bib100","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0068773","article-title":"Basic fibroblast growth factor contributes to a shift in the angioregulatory activity of retinal glial (M\u00fcller) cells","volume":"8","author":"Yafai","year":"2013","journal-title":"PLoS One"},{"issue":"19","key":"10.1016\/j.survophthal.2026.06.009_bib101","doi-asserted-by":"crossref","first-page":"4007","DOI":"10.1016\/j.cell.2023.07.036","article-title":"TGF-beta signaling in health and disease","volume":"186","author":"Massagu\u00e9","year":"2023","journal-title":"Cell"},{"issue":"5","key":"10.1016\/j.survophthal.2026.06.009_bib102","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25053052","article-title":"TGF-\u03b2 Signaling Pathways in the Development of Diabetic Retinopathy","volume":"25","author":"Callan","year":"2024","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10.1016\/j.survophthal.2026.06.009_bib103","doi-asserted-by":"crossref","first-page":"S24","DOI":"10.1186\/1755-1536-5-S1-S24","article-title":"CTGF is a central mediator of tissue remodeling and fibrosis and its inhibition can reverse the process of fibrosis","volume":"5","author":"Lipson","year":"2012","journal-title":"Fibrogenes & Tissue Repair"},{"issue":"2","key":"10.1016\/j.survophthal.2026.06.009_bib104","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1096\/fj.01-0332fje","article-title":"Connective tissue growth factor binds vascular endothelial growth factor (VEGF) and inhibits VEGF-induced angiogenesis","volume":"16","author":"Inoki","year":"2002","journal-title":"FASEB J"},{"issue":"9","key":"10.1016\/j.survophthal.2026.06.009_bib105","doi-asserted-by":"crossref","first-page":"4267","DOI":"10.1167\/iovs.06-0804","article-title":"Effect of VEGF-A on Expression of Profibrotic Growth Factor and Extracellular Matrix Genes in the Retina","volume":"48","author":"Kuiper","year":"2007","journal-title":"Invest Ophthalmol & Vis Sci"},{"key":"10.1016\/j.survophthal.2026.06.009_bib106","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.exer.2014.10.016","article-title":"The role of CTGF in diabetic retinopathy","volume":"133","author":"Klaassen","year":"2015","journal-title":"Exp Eye Res"},{"issue":"4","key":"10.1016\/j.survophthal.2026.06.009_bib107","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1210\/en.2007-1415","article-title":"Cysteine-Rich Protein 61 and Connective Tissue Growth Factor Induce Deadhesion and Anoikis of Retinal Pericytes","volume":"149","author":"Liu","year":"2008","journal-title":"Endocrinology"},{"issue":"8","key":"10.1016\/j.survophthal.2026.06.009_bib108","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1136\/bjo.2003.032045","article-title":"Differential expression of connective tissue growth factor in microglia and pericytes in the human diabetic retina","volume":"88","author":"Kuiper","year":"2004","journal-title":"Br J Ophthalmol"},{"issue":"4","key":"10.1016\/j.survophthal.2026.06.009_bib109","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1080\/02713680590923249","article-title":"A Single Local Injection of Recombinant VEGF Receptor 2 But Not of Tie2 Inhibits Retinal Neovascularization in the Mouse","volume":"30","author":"Agostini","year":"2005","journal-title":"Curr Eye Res"},{"issue":"48","key":"10.1016\/j.survophthal.2026.06.009_bib110","doi-asserted-by":"crossref","first-page":"40570","DOI":"10.1074\/jbc.M112.386565","article-title":"Connective Tissue Growth Factor Regulates Retinal Neovascularization through p53 Protein-dependent Transactivation of the Matrix Metalloproteinase (MMP)-2 Gene","volume":"287","author":"Chintala","year":"2012","journal-title":"J Biol Chem"},{"issue":"2","key":"10.1016\/j.survophthal.2026.06.009_bib111","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/S0002-9440(10)63311-1","article-title":"Insulin-like growth factor-I plays a pathogenetic role in diabetic retinopathy","volume":"165","author":"Poulaki","year":"2004","journal-title":"Am J Pathol"},{"issue":"8","key":"10.1016\/j.survophthal.2026.06.009_bib112","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1172\/JCI19478","article-title":"Increased ocular levels of IGF-1 in transgenic mice lead to diabetes-like eye disease","volume":"113","author":"Ruberte","year":"2004","journal-title":"J Clin Invest"},{"issue":"5319","key":"10.1016\/j.survophthal.2026.06.009_bib113","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1126\/science.276.5319.1706","article-title":"Essential role of growth hormone in ischemia-induced retinal neovascularization","volume":"276","author":"Smith","year":"1997","journal-title":"Science"},{"issue":"12","key":"10.1016\/j.survophthal.2026.06.009_bib114","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1172\/JCI200317455","article-title":"Knockout of insulin and IGF-1 receptors on vascular endothelial cells protects against retinal neovascularization","volume":"111","author":"Kondo","year":"2003","journal-title":"J Clin Invest"},{"issue":"3","key":"10.1016\/j.survophthal.2026.06.009_bib115","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1016\/j.biochi.2011.11.003","article-title":"Hypoxia-induced insulin-like growth factor II contributes to retinal vascularization in ocular development","volume":"94","author":"Kim","year":"2012","journal-title":"Biochimie"},{"issue":"4995","key":"10.1016\/j.survophthal.2026.06.009_bib116","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1126\/science.1846706","article-title":"Identification of the hepatocyte growth factor receptor as the c-met proto-oncogene product","volume":"251","author":"Bottaro","year":"1991","journal-title":"Science"},{"issue":"11","key":"10.1016\/j.survophthal.2026.06.009_bib117","first-page":"1997","article-title":"Expression of the Met\/HGF receptor in normal and neoplastic human tissues","volume":"6","author":"Di Renzo","year":"1991","journal-title":"Oncogene"},{"issue":"9","key":"10.1016\/j.survophthal.2026.06.009_bib118","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1042\/BC20080221","article-title":"Cross-talk between the VEGF-A and HGF signalling pathways in endothelial cells","volume":"101","author":"Sulpice","year":"2009","journal-title":"Biol Cell"},{"issue":"3","key":"10.1016\/j.survophthal.2026.06.009_bib119","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1016\/S0002-9440(10)64058-8","article-title":"Hepatocyte growth factor enhances vascular endothelial growth factor-induced angiogenesis in vitro and in vivo","volume":"158","author":"Xin","year":"2001","journal-title":"Am J Pathol"},{"issue":"2","key":"10.1016\/j.survophthal.2026.06.009_bib120","first-page":"659","article-title":"Increased vitreous concentrations of human hepatocyte growth factor in proliferative diabetic retinopathy","volume":"84","author":"Nishimura","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.survophthal.2026.06.009_bib121","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.semcdb.2014.03.004","article-title":"Heparin-binding epidermal growth factor-like growth factor (HB-EGF) and proteolytic processing by a disintegrin and metalloproteinases (ADAM): a regulator of several pathways","volume":"28","author":"Taylor","year":"2014","journal-title":"Semin Cell Dev Biol"},{"issue":"4","key":"10.1016\/j.survophthal.2026.06.009_bib122","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1080\/08977190701773070","article-title":"HB-EGF promotes angiogenesis in endothelial cells via PI3-kinase and MAPK signaling pathways","volume":"25","author":"Mehta","year":"2007","journal-title":"Growth Factors"},{"issue":"1","key":"10.1016\/j.survophthal.2026.06.009_bib123","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.oret.2017.04.004","article-title":"Bevacizumab Injection in Patients with Neovascular Age-Related Macular Degeneration Increases Angiogenic Biomarkers","volume":"2","author":"Cabral","year":"2018","journal-title":"Ophthalmol Retin"},{"issue":"9","key":"10.1016\/j.survophthal.2026.06.009_bib124","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0137358","article-title":"Elevated levels of cytokines associated with th2 and th17 cells in vitreous fluid of proliferative diabetic retinopathy patients","volume":"10","author":"Takeuchi","year":"2015","journal-title":"PLOS ONE"},{"issue":"3","key":"10.1016\/j.survophthal.2026.06.009_bib125","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0194603","article-title":"Anti-inflammatory cytokine and angiogenic factors levels in vitreous samples of diabetic retinopathy patients","volume":"13","author":"Tsai","year":"2018","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.survophthal.2026.06.009_bib126","doi-asserted-by":"crossref","first-page":"2645","DOI":"10.1073\/pnas.0437939100","article-title":"IL-1 is required for tumor invasiveness and angiogenesis","volume":"100","author":"Voronov","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"issue":"7","key":"10.1016\/j.survophthal.2026.06.009_bib127","doi-asserted-by":"crossref","first-page":"1952","DOI":"10.2337\/db07-1520","article-title":"Hyperglycemia-induced reactive oxygen species toxicity to endothelial cells is dependent on paracrine mediators","volume":"57","author":"Busik","year":"2008","journal-title":"Diabetes"},{"issue":"11","key":"10.1016\/j.survophthal.2026.06.009_bib128","doi-asserted-by":"crossref","first-page":"4342","DOI":"10.1167\/iovs.05-0601","article-title":"Anti-inflammatory effect of docosahexaenoic acid on cytokine-induced adhesion molecule expression in human retinal vascular endothelial cells","volume":"46","author":"Chen","year":"2005","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.survophthal.2026.06.009_bib129","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/935301","article-title":"Vitreous mediators in retinal hypoxic diseases","volume":"2013","author":"dell'Omo","year":"2013","journal-title":"Mediat Inflamm"},{"issue":"4","key":"10.1016\/j.survophthal.2026.06.009_bib130","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19040942","article-title":"Role of Inflammation in Diabetic Retinopathy","volume":"19","author":"R\u00fcbsam","year":"2018","journal-title":"Int J Mol Sci"},{"issue":"2","key":"10.1016\/j.survophthal.2026.06.009_bib131","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/S0002-9440(10)62284-5","article-title":"Inhibition of tumor necrosis factor-alpha improves physiological angiogenesis and reduces pathological neovascularization in ischemic retinopathy","volume":"166","author":"Gardiner","year":"2005","journal-title":"Am J Pathol"},{"issue":"6","key":"10.1016\/j.survophthal.2026.06.009_bib132","doi-asserted-by":"crossref","first-page":"2743","DOI":"10.1167\/iovs.02-1246","article-title":"Targeted disruption of the CD18 or ICAM-1 gene inhibits choroidal neovascularization","volume":"44","author":"Sakurai","year":"2003","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"1","key":"10.1016\/j.survophthal.2026.06.009_bib133","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1189\/jlb.0902436","article-title":"The critical role of ocular-infiltrating macrophages in the development of choroidal neovascularization","volume":"74","author":"Tsutsumi","year":"2003","journal-title":"J Leukoc Biol"},{"issue":"2","key":"10.1016\/j.survophthal.2026.06.009_bib134","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1161\/01.CIR.0000080735.93327.00","article-title":"Cyclooxygenase-2 in human and experimental ischemic proliferative retinopathy","volume":"108","author":"Sennlaub","year":"2003","journal-title":"Circulation"},{"issue":"Pt 2","key":"10.1016\/j.survophthal.2026.06.009_bib135","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1038\/eye.1993.58","article-title":"Histopathology of diabetic retinopathy in man","volume":"7","author":"Garner","year":"1993","journal-title":"Eye (Lond)"},{"issue":"2","key":"10.1016\/j.survophthal.2026.06.009_bib136","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.ajo.2010.03.016","article-title":"Histopathology of neovascular tissue from eyes with proliferative diabetic retinopathy after intravitreal bevacizumab injection","volume":"150","author":"Kohno","year":"2010","journal-title":"Am J Ophthalmol"},{"issue":"11","key":"10.1016\/j.survophthal.2026.06.009_bib137","first-page":"1338","article-title":"Diabetic neovascularization: permeability and ultrastructure","volume":"25","author":"Miller","year":"1984","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.survophthal.2026.06.009_bib138","first-page":"673","article-title":"Characterization of cells from patient-derived fibrovascular membranes in proliferative diabetic retinopathy","volume":"21","author":"Kim","year":"2015","journal-title":"Mol Vis"},{"issue":"6","key":"10.1016\/j.survophthal.2026.06.009_bib139","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1111\/aos.12741","article-title":"Indications of lymphatic endothelial differentiation and endothelial progenitor cell activation in the pathology of proliferative diabetic retinopathy","volume":"93","author":"Loukovaara","year":"2015","journal-title":"Acta Ophthalmol"},{"key":"10.1016\/j.survophthal.2026.06.009_bib140","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.exer.2014.10.021","article-title":"The role of extracellular matrix in retinal vascular development and preretinal neovascularization","volume":"133","author":"Bishop","year":"2015","journal-title":"Exp Eye Res"},{"key":"10.1016\/j.survophthal.2026.06.009_bib141","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.757607","article-title":"In-Depth Molecular Characterization of Neovascular Membranes Suggests a Role for Hyalocyte-to-Myofibroblast Transdifferentiation in Proliferative Diabetic Retinopathy","volume":"12","author":"Boneva","year":"2021","journal-title":"Front Immunol"},{"issue":"9","key":"10.1016\/j.survophthal.2026.06.009_bib142","doi-asserted-by":"crossref","first-page":"2765","DOI":"10.1007\/s00417-024-06448-3","article-title":"Hyalocytes\u2014guardians of the vitreoretinal interface","volume":"262","author":"Lange","year":"2024","journal-title":"Graefe's Arch Clin Exp Ophthalmol"},{"issue":"1","key":"10.1016\/j.survophthal.2026.06.009_bib143","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-025-05199-3","article-title":"Different distribution and density of myofibroblasts in idiopathic epiretinal membrane and epiretinal membrane in proliferative diabetic retinopathy","volume":"15","author":"Tien","year":"2025","journal-title":"Sci Rep"},{"key":"10.1016\/j.survophthal.2026.06.009_bib144","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.exer.2015.04.004","article-title":"Retinal fibrosis in diabetic retinopathy","volume":"142","author":"Roy","year":"2016","journal-title":"Exp Eye Res"},{"issue":"7","key":"10.1016\/j.survophthal.2026.06.009_bib145","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1097\/IAE.0000000000001336","article-title":"Tomographic Relationships Between Retinal Neovascularization and the Posterior Vitreous in Proliferative Diabetic Retinopathy","volume":"37","author":"Vaz-Pereira","year":"2017","journal-title":"Retina"},{"issue":"8","key":"10.1016\/j.survophthal.2026.06.009_bib146","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1007\/s00417-004-0980-1","article-title":"Anomalous posterior vitreous detachment: a unifying concept in vitreo-retinal disease","volume":"242","author":"Sebag","year":"2004","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"3","key":"10.1016\/j.survophthal.2026.06.009_bib147","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/s00417-007-0743-x","article-title":"Vitreoschisis","volume":"246","author":"Sebag","year":"2008","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.survophthal.2026.06.009_bib148","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s40942-020-00230-3","article-title":"Optical coherence tomography features of neovascularization in proliferative diabetic retinopathy: a systematic review","volume":"6","author":"Vaz-Pereira","year":"2020","journal-title":"Int J Retin Vitr"},{"issue":"6","key":"10.1016\/j.survophthal.2026.06.009_bib149","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1097\/IAE.0000000000000869","article-title":"Optical coherence tomography features of active and inactive retinal neovascularization in proliferative diabetic retinopathy","volume":"36","author":"Vaz-Pereira","year":"2016","journal-title":"Retina"},{"issue":"1-2","key":"10.1016\/j.survophthal.2026.06.009_bib150","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s10792-005-5389-2","article-title":"Prospective assessment of proliferative diabetic retinopathy with observations of posterior vitreous detachment","volume":"26","author":"Ono","year":"2005","journal-title":"Int Ophthalmol"},{"issue":"8","key":"10.1016\/j.survophthal.2026.06.009_bib151","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1111\/aos.16755","article-title":"Vitreoschisis-induced vitreous cortex remnants in proliferative vitreoretinopathy: A comprehensive review from basic research to clinical practice","volume":"102","author":"van Overdam","year":"2024","journal-title":"Acta Ophthalmol"},{"key":"10.1016\/j.survophthal.2026.06.009_bib152","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.ajo.2015.10.025","article-title":"Three-Dimensional Enhanced Imaging of Vitreoretinal Interface in Diabetic Retinopathy Using Swept-Source Optical Coherence Tomography","volume":"162","author":"Adhi","year":"2016","journal-title":"Am J Ophthalmol"},{"issue":"2","key":"10.1016\/j.survophthal.2026.06.009_bib153","first-page":"233","article-title":"Risk factors for high-risk proliferative diabetic retinopathy and severe visual loss: early treatment diabetic retinopathy study report #18","volume":"39","author":"Davis","year":"1998","journal-title":"Invest Ophthalmol & Vis Sci"},{"issue":"7","key":"10.1016\/j.survophthal.2026.06.009_bib154","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1136\/bjophthalmol-2013-304452","article-title":"Swept-source optical coherence tomography imaging of the cortical vitreous and the vitreoretinal interface in proliferative diabetic retinopathy: assessment of vitreoschisis, neovascularisation and the internal limiting membrane","volume":"98","author":"Muqit","year":"2014","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.survophthal.2026.06.009_bib155","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.ajo.2018.05.018","article-title":"Characteristics of neovascularization in early stages of proliferative diabetic retinopathy by optical coherence tomography angiography","volume":"192","author":"Pan","year":"2018","journal-title":"Am J Ophthalmol"},{"issue":"9","key":"10.1016\/j.survophthal.2026.06.009_bib156","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1007\/s40123-025-01213-z","article-title":"Assessment of relationship between neovascularization type using wide field optical coherence tomography angiography in eyes with proliferative diabetic retinopathy","volume":"14","author":"Aggarwal","year":"2025","journal-title":"Ophthalmol Ther"},{"issue":"14","key":"10.1016\/j.survophthal.2026.06.009_bib157","doi-asserted-by":"crossref","first-page":"6247","DOI":"10.1167\/iovs.16-20210","article-title":"Characteristics of Retinal Neovascularization in Proliferative Diabetic Retinopathy Imaged by Optical Coherence Tomography Angiography","volume":"57","author":"Ishibazawa","year":"2016","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.survophthal.2026.06.009_bib158","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.ajo.2019.04.023","article-title":"Distribution of nonperfusion and neovascularization on ultrawide-field fluorescein angiography in proliferative diabetic retinopathy (RECOVERY Study): Report 1","volume":"206","author":"Fan","year":"2019","journal-title":"Am J Ophthalmol"},{"issue":"1","key":"10.1016\/j.survophthal.2026.06.009_bib159","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.ajo.2014.09.041","article-title":"Reevaluating the definition of intraretinal microvascular abnormalities and neovascularization elsewhere in diabetic retinopathy using optical coherence tomography and fluorescein angiography","volume":"159","author":"Lee","year":"2015","journal-title":"Am J Ophthalmol"},{"issue":"1","key":"10.1016\/j.survophthal.2026.06.009_bib160","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1001\/jamaophthalmol.2014.3616","article-title":"Retinal vascular layers imaged by fluorescein angiography and optical coherence tomography angiography","volume":"133","author":"Spaide","year":"2015","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.survophthal.2026.06.009_bib161","doi-asserted-by":"crossref","first-page":"3351","DOI":"10.2147\/OPTH.S274537","article-title":"Optical coherence tomography angiography features of neovascularization in proliferative diabetic retinopathy","volume":"14","author":"Vaz-Pereira","year":"2020","journal-title":"Clin Ophthalmol"},{"issue":"2","key":"10.1016\/j.survophthal.2026.06.009_bib162","doi-asserted-by":"crossref","first-page":"115","DOI":"10.3928\/23258160-20160126-03","article-title":"Evaluation of Preretinal Neovascularization in Proliferative Diabetic Retinopathy Using Optical Coherence Tomography Angiography","volume":"47","author":"de Carlo","year":"2016","journal-title":"Ophthalmic Surg Lasers Imaging Retin"},{"issue":"9","key":"10.1016\/j.survophthal.2026.06.009_bib163","first-page":"1528","article-title":"Bimodal imaging of proliferative diabetic retinopathy vascular features using swept source optical coherence tomography angiography","volume":"11","author":"Elbendary","year":"2018","journal-title":"Int J Ophthalmol"},{"issue":"1","key":"10.1016\/j.survophthal.2026.06.009_bib164","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1186\/s12886-021-01964-w","article-title":"Observation of retinal neovascularization using optical coherence tomography angiography after panretinal photocoagulation for proliferative diabetic retinopathy","volume":"21","author":"Feng","year":"2021","journal-title":"BMC Ophthalmol"},{"key":"10.1016\/j.survophthal.2026.06.009_bib165","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/2942197","article-title":"Characterizing Flow and Structure of Diabetic Retinal Neovascularization after Intravitreal Anti-VEGF Using Optical Coherence Tomography Angiography: A Pilot Study","volume":"2021","author":"Haensli","year":"2021","journal-title":"J Ophthalmol"},{"issue":"5","key":"10.1016\/j.survophthal.2026.06.009_bib166","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1001\/jamaophthalmol.2021.0108","article-title":"Topographical Response of Retinal Neovascularization to Aflibercept or Panretinal Photocoagulation in Proliferative Diabetic Retinopathy: Post Hoc Analysis of the CLARITY Randomized Clinical Trial","volume":"139","author":"Halim","year":"2021","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.survophthal.2026.06.009_bib167","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.ajo.2020.01.024","article-title":"Retinal Nonperfusion in Proliferative Diabetic Retinopathy Before and After Panretinal Photocoagulation Assessed by Widefield OCT Angiography","volume":"213","author":"Russell","year":"2020","journal-title":"Am J Ophthalmol"},{"issue":"4","key":"10.1016\/j.survophthal.2026.06.009_bib168","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.oret.2018.11.008","article-title":"Longitudinal Wide-Field Swept-Source OCT Angiography of Neovascularization in Proliferative Diabetic Retinopathy after Panretinal Photocoagulation","volume":"3","author":"Russell","year":"2019","journal-title":"Ophthalmol Retin"},{"issue":"1","key":"10.1016\/j.survophthal.2026.06.009_bib169","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s40942-020-00249-6","article-title":"Optical coherence tomography angiography measured area of retinal neovascularization is predictive of treatment response and progression of disease in patients with proliferative diabetic retinopathy","volume":"6","author":"Vergmann","year":"2020","journal-title":"Int J Retin Vitr"},{"issue":"9","key":"10.1016\/j.survophthal.2026.06.009_bib170","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1016\/j.ophtha.2021.02.020","article-title":"Widefield Swept-Source OCT Angiography Metrics Associated with the Development of Diabetic Vitreous Hemorrhage: A Prospective Study","volume":"128","author":"Cui","year":"2021","journal-title":"Ophthalmology"},{"key":"10.1016\/j.survophthal.2026.06.009_bib171","article-title":"Expanded field OCTA Biomarkers Associated with the Development of Tractional Retinal Detachment in Proliferative Diabetic Retinopathy","author":"Lu","year":"2025","journal-title":"RETINA"},{"issue":"5","key":"10.1016\/j.survophthal.2026.06.009_bib172","doi-asserted-by":"crossref","first-page":"2511","DOI":"10.1177\/1120672120963451","article-title":"OCT-Angiography as a reliable prognostic tool in laser-treated proliferative diabetic retinopathy: The RENOCTA Study","volume":"31","author":"Lupidi","year":"2020","journal-title":"Eur J Ophthalmol"},{"issue":"12","key":"10.1016\/j.survophthal.2026.06.009_bib173","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1016\/j.ophtha.2019.06.022","article-title":"Widefield OCT-Angiography and Fluorescein Angiography Assessments of Nonperfusion in Diabetic Retinopathy and Edema Treated with Anti-Vascular Endothelial Growth Factor","volume":"126","author":"Couturier","year":"2019","journal-title":"Ophthalmology"},{"issue":"1","key":"10.1016\/j.survophthal.2026.06.009_bib174","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1038\/s41377-022-00740-9","article-title":"Towards standardizing retinal optical coherence tomography angiography: a review","volume":"11","author":"Sampson","year":"2022","journal-title":"Light Science & Applications"},{"key":"10.1016\/j.survophthal.2026.06.009_bib175","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/S0161-6420(13)38013-0","article-title":"Classification of diabetic retinopathy from fluorescein angiograms. ETDRS report number 11","volume":"98","author":"Early Treatment Diabetic Retinopathy Research Group.","year":"1991","journal-title":"Ophthalmology"},{"issue":"7","key":"10.1016\/j.survophthal.2026.06.009_bib176","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/S0161-6420(81)34983-5","article-title":"Midperipheral fundus involvement in diabetic retinopathy","volume":"88","author":"Shimizu","year":"1981","journal-title":"Ophthalmology"},{"issue":"12","key":"10.1016\/j.survophthal.2026.06.009_bib177","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.1016\/j.ophtha.2015.07.034","article-title":"Diabetic Retinopathy Severity and Peripheral Lesions Are Associated with Nonperfusion on Ultrawide Field Angiography","volume":"122","author":"Silva","year":"2015","journal-title":"Ophthalmology"},{"issue":"4","key":"10.1016\/j.survophthal.2026.06.009_bib178","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1097\/IAE.0b013e3182278b64","article-title":"Ultra-wide-field angiography improves the detection and classification of diabetic retinopathy","volume":"32","author":"Wessel","year":"2012","journal-title":"Retina"},{"issue":"11","key":"10.1016\/j.survophthal.2026.06.009_bib179","doi-asserted-by":"crossref","first-page":"2371","DOI":"10.1097\/IAE.0000000000000716","article-title":"Optical Coherence Tomography Angiography Features of Diabetic Retinopathy","volume":"35","author":"Hwang","year":"2015","journal-title":"RETINA"},{"key":"10.1016\/j.survophthal.2026.06.009_bib180","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.visres.2017.05.006","article-title":"OCT angiography and visible-light OCT in diabetic retinopathy","volume":"139","author":"Nesper","year":"2017","journal-title":"Vision Res"},{"key":"10.1016\/j.survophthal.2026.06.009_bib181","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/S0161-6420(13)38015-4","article-title":"Fluorescein angiographic risk factors for progression of diabetic retinopathy. ETDRS report number 13","volume":"98","author":"Early Treatment Diabetic Retinopathy Research Group.","year":"1991","journal-title":"Ophthalmology"},{"issue":"1","key":"10.1016\/j.survophthal.2026.06.009_bib182","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/s40942-024-00603-y","article-title":"Diabetic macular edema (DME): dissecting pathogenesis, prognostication, diagnostic modalities along with current and futuristic therapeutic insights","volume":"10","author":"Sakini","year":"2024","journal-title":"Int J Retin Vitr"},{"issue":"10","key":"10.1016\/j.survophthal.2026.06.009_bib183","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1001\/jamaophthalmol.2022.3130","article-title":"Association of Ultra-Widefield Fluorescein Angiography-Identified Retinal Nonperfusion and the Risk of Diabetic Retinopathy Worsening Over Time","volume":"140","author":"Silva","year":"2022","journal-title":"JAMA Ophthalmol"},{"issue":"5","key":"10.1016\/j.survophthal.2026.06.009_bib184","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.survophthal.2019.02.004","article-title":"Adverse reactions to fluorescein angiography: A comprehensive review of the literature","volume":"64","author":"Kornblau","year":"2019","journal-title":"Surv Ophthalmol"},{"issue":"8","key":"10.1016\/j.survophthal.2026.06.009_bib185","doi-asserted-by":"crossref","first-page":"968","DOI":"10.2337\/diab.44.8.968","article-title":"The Relationship of Glycemic Exposure (HbA1c) to the Risk of Development and Progression of Retinopathy in the Diabetes Control and Complications Trial","volume":"44","author":"The Diabetes Control and Complications Trial Research Group.","year":"1995","journal-title":"Diabetes"},{"issue":"11","key":"10.1016\/j.survophthal.2026.06.009_bib186","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1016\/j.ophtha.2008.08.023","article-title":"The Wisconsin Epidemiologic Study of Diabetic Retinopathy: XXII the twenty-five-year progression of retinopathy in persons with type 1 diabetes","volume":"115","author":"Klein","year":"2008","journal-title":"Ophthalmology"},{"issue":"14","key":"10.1016\/j.survophthal.2026.06.009_bib187","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1056\/NEJM199309303291401","article-title":"The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus","volume":"329","author":"Nathan","year":"1993","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.survophthal.2026.06.009_bib188","article-title":"Prognostic factors for the development and progression of proliferative diabetic retinopathy in people with diabetic retinopathy","author":"Perais","year":"2023","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"10.1016\/j.survophthal.2026.06.009_bib189","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1007\/s001250051594","article-title":"UKPDS 50: risk factors for incidence and progression of retinopathy in Type II diabetes over 6 years from diagnosis","volume":"44","author":"Stratton","year":"2001","journal-title":"Diabetologia"},{"key":"10.1016\/j.survophthal.2026.06.009_bib190","doi-asserted-by":"crossref","first-page":"628","DOI":"10.31128\/AJGP-03-21-5866","article-title":"HbA1c: More than just a number","volume":"50","author":"Wang","year":"2021","journal-title":"Aust J General Pract"},{"issue":"9153","key":"10.1016\/j.survophthal.2026.06.009_bib191","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/S0140-6736(98)07368-1","article-title":"O. Intensified multifactorial intervention in patients with type 2 diabetes mellitus and microalbuminuria: the Steno type 2 randomised study","volume":"353","author":"Gaede","year":"1999","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.survophthal.2026.06.009_bib192","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.diabet.2017.10.014","article-title":"Early worsening of diabetic retinopathy after rapid improvement of blood glucose control in patients with diabetes","volume":"44","author":"Feldman-Billard","year":"2018","journal-title":"Diabetes & Metab"},{"issue":"2","key":"10.1016\/j.survophthal.2026.06.009_bib193","doi-asserted-by":"crossref","first-page":"308","DOI":"10.2337\/dc14-1203","article-title":"Impact of HbA1c, followed from onset of type 1 diabetes, on the development of severe retinopathy and nephropathy: the VISS Study (Vascular Diabetic Complications in Southeast Sweden)","volume":"38","author":"Nordwall","year":"2015","journal-title":"Diabetes Care"},{"key":"10.1016\/j.survophthal.2026.06.009_bib194","doi-asserted-by":"crossref","first-page":"l4894","DOI":"10.1136\/bmj.l4894","article-title":"HbA1c level as a risk factor for retinopathy and nephropathy in children and adults with type 1 diabetes: Swedish population based cohort study","volume":"366","author":"Lind","year":"2019","journal-title":"BMJ"},{"issue":"12","key":"10.1016\/j.survophthal.2026.06.009_bib195","doi-asserted-by":"crossref","first-page":"2443","DOI":"10.1016\/j.ophtha.2014.07.019","article-title":"The Effects of Medical Management on the Progression of Diabetic Retinopathy in Persons with Type 2 Diabetes: The Action to Control Cardiovascular Risk in Diabetes (ACCORD) Eye Study","volume":"121","author":"Chew","year":"2014","journal-title":"Ophthalmology"},{"issue":"7160","key":"10.1016\/j.survophthal.2026.06.009_bib196","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1136\/bmj.317.7160.703","article-title":"Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38","volume":"317","author":"UK Prospective Diabetes Study Group.","year":"1998","journal-title":"Bmj"},{"issue":"2","key":"10.1016\/j.survophthal.2026.06.009_bib197","doi-asserted-by":"crossref","first-page":"527","DOI":"10.2337\/diabetes.54.2.527","article-title":"The relationship of diabetic retinopathy to preclinical diabetic glomerulopathy lesions in type 1 diabetic patients: the Renin-Angiotensin System Study","volume":"54","author":"Klein","year":"2005","journal-title":"Diabetes"},{"issue":"6","key":"10.1016\/j.survophthal.2026.06.009_bib198","doi-asserted-by":"crossref","DOI":"10.3390\/jcm10061254","article-title":"Integrative Biology of Diabetic Retinal Disease: Lessons from Diabetic Kidney Disease","volume":"10","author":"Pan","year":"2021","journal-title":"J Clin Med"},{"issue":"1","key":"10.1016\/j.survophthal.2026.06.009_bib199","doi-asserted-by":"crossref","DOI":"10.1136\/bmjdrc-2019-000726","article-title":"Retinopathy progression and the risk of end-stage kidney disease: results from a longitudinal Japanese cohort of 232 patients with type 2 diabetes and biopsy-proven diabetic kidney disease","volume":"7","author":"Yamanouchi","year":"2019","journal-title":"BMJ Open Diabetes Res & Care"},{"issue":"1","key":"10.1016\/j.survophthal.2026.06.009_bib200","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1758-5996-3-9","article-title":"Albuminuria and Diabetic Retinopathy in Type 2 Diabetes Mellitus Sankara Nethralaya Diabetic Retinopathy Epidemiology And Molecular Genetic Study (SN-DREAMS, report 12)","volume":"3","author":"Rani","year":"2011","journal-title":"Diabetol Metab Syndr"},{"issue":"4","key":"10.1016\/j.survophthal.2026.06.009_bib201","doi-asserted-by":"crossref","first-page":"803","DOI":"10.2337\/dc11-1955","article-title":"More impact of microalbuminuria on retinopathy than moderately reduced GFR among type 2 diabetic patients","volume":"35","author":"Chen","year":"2012","journal-title":"Diabetes Care"},{"issue":"4","key":"10.1016\/j.survophthal.2026.06.009_bib202","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1007\/s00125-022-05655-z","article-title":"Lipids, hyperreflective crystalline deposits and diabetic retinopathy: potential systemic and retinal-specific effect of lipid-lowering therapies","volume":"65","author":"Jenkins","year":"2022","journal-title":"Diabetologia"},{"issue":"9600","key":"10.1016\/j.survophthal.2026.06.009_bib203","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1016\/S0140-6736(07)61607-9","article-title":"Effect of fenofibrate on the need for laser treatment for diabetic retinopathy (FIELD study): a randomised controlled trial","volume":"370","author":"Keech","year":"2007","journal-title":"Lancet"},{"issue":"8","key":"10.1016\/j.survophthal.2026.06.009_bib204","doi-asserted-by":"crossref","DOI":"10.1056\/EVIDoa2400179","article-title":"Effect of Fenofibrate on Progression of Diabetic Retinopathy","volume":"3","author":"Preiss","year":"2024","journal-title":"NEJM Evid"},{"issue":"8","key":"10.1016\/j.survophthal.2026.06.009_bib205","doi-asserted-by":"crossref","DOI":"10.1056\/EVIDe2400205","article-title":"Fenofibrate Shows Promise in Slowing Diabetic Retinopathy Progression","volume":"3","author":"Silva","year":"2024","journal-title":"NEJM Evid"},{"issue":"5","key":"10.1016\/j.survophthal.2026.06.009_bib206","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1038\/s41433-019-0617-6","article-title":"Anaemia and the risk of progression from non-proliferative diabetic retinopathy to vision threatening diabetic retinopathy","volume":"34","author":"Li","year":"2020","journal-title":"Eye (Lond)"},{"issue":"7","key":"10.1016\/j.survophthal.2026.06.009_bib207","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.2337\/dc08-0779","article-title":"Anemia, diabetes, and chronic kidney disease","volume":"32","author":"Mehdi","year":"2009","journal-title":"Diabetes Care"},{"issue":"19","key":"10.1016\/j.survophthal.2026.06.009_bib208","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1056\/NEJMoa1607141","article-title":"Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes","volume":"375","author":"Marso","year":"2016","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.survophthal.2026.06.009_bib209","doi-asserted-by":"crossref","first-page":"290","DOI":"10.2337\/dc20-1815","article-title":"HbA(1c) Change and Diabetic Retinopathy During GLP-1 Receptor Agonist Cardiovascular Outcome Trials: A Meta-analysis and Meta-regression","volume":"44","author":"Bethel","year":"2021","journal-title":"Diabetes Care"},{"issue":"3","key":"10.1016\/j.survophthal.2026.06.009_bib210","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1111\/dom.13538","article-title":"Worsening of diabetic retinopathy with rapid improvement in systemic glucose control: A review","volume":"21","author":"Bain","year":"2019","journal-title":"Diabetes Obes Metab"},{"issue":"1","key":"10.1016\/j.survophthal.2026.06.009_bib211","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1007\/s10792-025-03768-z","article-title":"SGLT2 inhibitors for delaying diabetic retinopathy: a systematic review and meta-analysis","volume":"45","author":"Goodarzi","year":"2025","journal-title":"Int Ophthalmol"},{"key":"10.1016\/j.survophthal.2026.06.009_bib212","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.ajo.2024.04.010","article-title":"Impact of GLP-1 Agonists and SGLT-2 Inhibitors on Diabetic Retinopathy Progression: An Aggregated Electronic Health Record Data Study","volume":"265","author":"Wai","year":"2024","journal-title":"Am J Ophthalmol"},{"issue":"1","key":"10.1016\/j.survophthal.2026.06.009_bib213","article-title":"Sodium-glucose co-transporter 2 inhibitor add-on therapy for metformin delays diabetic retinopathy progression in diabetes patients: a population-based cohort study","volume":"13","author":"Li","year":"2023","journal-title":"Sci Rep"},{"issue":"5","key":"10.1016\/j.survophthal.2026.06.009_bib214","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/j.ophtha.2015.01.008","article-title":"Peripheral Lesions Identified on Ultrawide Field Imaging Predict Increased Risk of Diabetic Retinopathy Progression over 4 Years","volume":"122","author":"Silva","year":"2015","journal-title":"Ophthalmology"},{"issue":"6","key":"10.1016\/j.survophthal.2026.06.009_bib215","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1001\/jamaophthalmol.2019.0440","article-title":"Retinal Nonperfusion Characteristics on Ultra-Widefield Angiography in Eyes With Severe Nonproliferative Diabetic Retinopathy and Proliferative Diabetic Retinopathy","volume":"137","author":"Nicholson","year":"2019","journal-title":"JAMA Ophthalmol"},{"issue":"8","key":"10.1016\/j.survophthal.2026.06.009_bib216","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1111\/ceo.12557","article-title":"Diagnostic accuracy of disorganization of the retinal inner layers in detecting macular capillary non-perfusion in diabetic retinopathy","volume":"43","author":"Nicholson","year":"2015","journal-title":"Clin Exp Ophthalmol"},{"issue":"11","key":"10.1016\/j.survophthal.2026.06.009_bib217","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1001\/jamaophthalmol.2014.2350","article-title":"Disorganization of the retinal inner layers as a predictor of visual acuity in eyes with center-involved diabetic macular edema","volume":"132","author":"Sun","year":"2014","journal-title":"JAMA Ophthalmol"},{"issue":"2","key":"10.1016\/j.survophthal.2026.06.009_bib218","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1167\/iovs.66.2.32","article-title":"Relationship of OCT-Based Diabetic Retinal Neurodegeneration to the Development and Progression of Diabetic Retinopathy: A Cohort Study","volume":"66","author":"Tang","year":"2025","journal-title":"Invest Ophthalmol & Vis Sci"},{"issue":"18","key":"10.1016\/j.survophthal.2026.06.009_bib219","doi-asserted-by":"crossref","first-page":"3781","DOI":"10.1038\/s41433-023-02605-w","article-title":"Association of OCT and OCT angiography measures with the development and worsening of diabetic retinopathy in type 2 diabetes","volume":"37","author":"Srinivasan","year":"2023","journal-title":"Eye (Lond)"},{"issue":"12","key":"10.1016\/j.survophthal.2026.06.009_bib220","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1016\/j.ophtha.2019.06.016","article-title":"OCT Angiography Metrics Predict Progression of Diabetic Retinopathy and Development of Diabetic Macular Edema: A Prospective Study","volume":"126","author":"Sun","year":"2019","journal-title":"Ophthalmology"},{"key":"10.1016\/j.survophthal.2026.06.009_bib221","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.ajo.2020.06.009","article-title":"Macular and Peripapillary Optical Coherence Tomography Angiography Metrics Predict Progression in Diabetic Retinopathy: A Sub-analysis of TIME-2b Study Data","volume":"219","author":"Custo Greig","year":"2020","journal-title":"Am J Ophthalmol"},{"issue":"11","key":"10.1016\/j.survophthal.2026.06.009_bib222","doi-asserted-by":"crossref","DOI":"10.3390\/jcm10112296","article-title":"Optical Coherence Tomography Angiography Metrics Monitor Severity Progression of Diabetic Retinopathy-3-Year Longitudinal Study","volume":"10","author":"Marques","year":"2021","journal-title":"J Clin Med"},{"issue":"4","key":"10.1016\/j.survophthal.2026.06.009_bib223","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0249918","article-title":"A Swept source optical coherence tomography angiography study: Imaging artifacts and comparison of non-perfusion areas with fluorescein angiography in diabetic macular edema","volume":"16","author":"Podkowinski","year":"2021","journal-title":"PLoS One"},{"issue":"9","key":"10.1016\/j.survophthal.2026.06.009_bib224","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1001\/archopht.1984.01040031057023","article-title":"Electroretinographic oscillatory potentials predict progression of diabetic retinopathy. Preliminary report","volume":"102","author":"Bresnick","year":"1984","journal-title":"Arch Ophthalmol"},{"issue":"6","key":"10.1016\/j.survophthal.2026.06.009_bib225","doi-asserted-by":"crossref","DOI":"10.1016\/j.xops.2025.100859","article-title":"Predicting Progression to Vision-Threatening Complications in Diabetic Retinopathy","volume":"5","author":"Davis","year":"2025","journal-title":"Ophthalmol Sci"},{"issue":"8","key":"10.1016\/j.survophthal.2026.06.009_bib226","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1136\/bjo.2003.032656","article-title":"S. Risk evaluation of outcome of vitreous surgery for proliferative diabetic retinopathy based on vitreous level of vascular endothelial growth factor and angiotensin II","volume":"88","author":"Funatsu","year":"2004","journal-title":"Br J Ophthalmol"},{"issue":"6","key":"10.1016\/j.survophthal.2026.06.009_bib227","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1097\/IAE.0b013e31816576d5","article-title":"Proinflammatory cytokines and angiogenic and anti-angiogenic factors in vitreous of patients with proliferative diabetic retinopathy and eales' disease","volume":"28","author":"Murugeswari","year":"2008","journal-title":"Retina"},{"key":"10.1016\/j.survophthal.2026.06.009_bib228","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/8784139","article-title":"Progression of Diabetic Retinopathy and Declining Renal Function in Patients with Type 2 Diabetes","volume":"2020","author":"Cho","year":"2020","journal-title":"J Diabetes Res"},{"issue":"1","key":"10.1016\/j.survophthal.2026.06.009_bib229","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1186\/s12886-022-02439-2","article-title":"Correlation between the progression of diabetic retinopathy and inflammasome biomarkers in vitreous and serum \u2013 a systematic review","volume":"22","author":"Kuo","year":"2022","journal-title":"BMC Ophthalmol"},{"issue":"5","key":"10.1016\/j.survophthal.2026.06.009_bib230","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1038\/sj.eye.6701920","article-title":"Involvement of circulating endothelial progenitor cells and vasculogenic factors in the pathogenesis of diabetic retinopathy","volume":"20","author":"Lee","year":"2006","journal-title":"Eye (Lond)"},{"issue":"1","key":"10.1016\/j.survophthal.2026.06.009_bib231","article-title":"Normal-to-mildly increased albuminuria predicts the risk for diabetic retinopathy in patients with type 2 diabetes","volume":"7","author":"Lee","year":"2017","journal-title":"Sci Rep"},{"issue":"4","key":"10.1016\/j.survophthal.2026.06.009_bib232","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1001\/jamaophthalmol.2013.2299","article-title":"Prospective Study of Inflammatory Biomarkers and Risk of Diabetic Retinopathy in the Diabetes Control and Complications Trial","volume":"131","author":"Muni","year":"2013","journal-title":"JAMA Ophthalmol"},{"issue":"7","key":"10.1016\/j.survophthal.2026.06.009_bib233","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1097\/IAE.0000000000003049","article-title":"Effects of Glycemic Variability on the Progression of Diabetic Retinopathy Among Patients with Type 2 Diabetes","volume":"41","author":"Park","year":"2021","journal-title":"Retina"},{"issue":"13","key":"10.1016\/j.survophthal.2026.06.009_bib234","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1042\/CS20200085","article-title":"Pathogenic role of human C-reactive protein in diabetic retinopathy","volume":"134","author":"Qiu","year":"2020","journal-title":"Clin Sci (Lond)"},{"issue":"3","key":"10.1016\/j.survophthal.2026.06.009_bib235","doi-asserted-by":"crossref","first-page":"612","DOI":"10.3390\/futurepharmacol3030039","article-title":"Systemic Inflammasome Biomarkers as Predictors of Diabetic Retinopathy Progression: Evidence from a Pilot Study","volume":"3","author":"Kuo","year":"2023","journal-title":"Future Pharmacol"},{"issue":"4","key":"10.1016\/j.survophthal.2026.06.009_bib236","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1167\/iovs.61.4.33","article-title":"Posterior Vitreous Detachment in Highly Myopic Patients","volume":"61","author":"Hayashi","year":"2020","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"8","key":"10.1016\/j.survophthal.2026.06.009_bib237","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1167\/tvst.14.8.39","article-title":"Retinal and Choroidal Vascular Biomarkers Are Correlated With the Degree of Myopia","volume":"14","author":"Park","year":"2025","journal-title":"Transl Vis Sci Technol"},{"issue":"6","key":"10.1016\/j.survophthal.2026.06.009_bib238","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1080\/09286586.2025.2546322","article-title":"Genetic Associations of Myopia and Axial Length with Diabetic Retinopathy","volume":"32","author":"Kai","year":"2025","journal-title":"Ophthalmic Epidemiol"},{"issue":"1","key":"10.1016\/j.survophthal.2026.06.009_bib239","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0161-6420(94)31353-4","article-title":"Ocular Factors in the Incidence and Progression of Diabetic Retinopathy","volume":"101","author":"Moss","year":"1994","journal-title":"Ophthalmology"},{"issue":"4","key":"10.1016\/j.survophthal.2026.06.009_bib240","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1097\/OPX.0b013e31824c5270","article-title":"Axial length and proliferative diabetic retinopathy","volume":"89","author":"Yang","year":"2012","journal-title":"Optom Vis Sci"},{"issue":"1","key":"10.1016\/j.survophthal.2026.06.009_bib241","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/s40942-024-00593-x","article-title":"Is longer axial length protective of vision-threatening diabetic retinopathy across different ages? A multicenter cohort of 736 patients","volume":"10","author":"Xu","year":"2024","journal-title":"Int J Retin Vitr"},{"issue":"8","key":"10.1016\/j.survophthal.2026.06.009_bib242","first-page":"1091","article-title":"Progression of Diabetic Retinopathy in Presence of Age-related Macular Degeneration","volume":"62","author":"Roh","year":"2021","journal-title":"Invest Ophthalmol & Vis Sci"},{"issue":"11","key":"10.1016\/j.survophthal.2026.06.009_bib243","doi-asserted-by":"crossref","first-page":"3184","DOI":"10.4103\/ijo.IJO_1175_21","article-title":"Impact of age-related macular degeneration on diabetic retinopathy: An electronic health record based big data analysis from a tertiary eye centre in South India","volume":"69","author":"Sahoo","year":"2021","journal-title":"Indian J Ophthalmol"},{"issue":"9","key":"10.1016\/j.survophthal.2026.06.009_bib244","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1016\/S0886-3350(99)00161-3","article-title":"Postoperative inflammation: extracapsular cataract extraction versus phacoemulsification","volume":"25","author":"Chee","year":"1999","journal-title":"J Cataract & Refract Surg"},{"key":"10.1016\/j.survophthal.2026.06.009_bib245","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1016\/S0886-3350(96)80160-X","article-title":"Postoperative inflammatory response to phacoemulsification and extracapsular cataract surgery: Aqueous flare and cells","volume":"22","author":"Pande","year":"1996","journal-title":"J Cataract & Refract Surg"},{"issue":"9","key":"10.1016\/j.survophthal.2026.06.009_bib246","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1136\/bjo.75.9.547","article-title":"Progression of diabetic retinopathy after cataract extraction","volume":"75","author":"Pollack","year":"1991","journal-title":"Br J Ophthalmol"},{"issue":"4","key":"10.1016\/j.survophthal.2026.06.009_bib247","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/S0002-9394(14)71857-4","article-title":"Progression of Nonproliferative Diabetic Retinopathy and Visual Outcome After Extracapsular Cataract Extraction and Intraocular Lens Implantation","volume":"114","author":"Jaffe","year":"1992","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.survophthal.2026.06.009_bib248","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.ajo.2024.08.017","article-title":"Incidence and Progression of Diabetic Retinopathy After Cataract Surgery: A Systematic Review and Meta-Analysis","volume":"269","author":"Lee","year":"2025","journal-title":"Am J Ophthalmol"},{"issue":"7","key":"10.1016\/j.survophthal.2026.06.009_bib249","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/j.ophtha.2025.02.006","article-title":"Risk of Progression of Nonproliferative to Proliferative Diabetic Retinopathy after Cataract Surgery","volume":"132","author":"Loya","year":"2025","journal-title":"Ophthalmology"},{"issue":"12","key":"10.1016\/j.survophthal.2026.06.009_bib250","doi-asserted-by":"crossref","first-page":"3233","DOI":"10.1007\/s10792-020-01507-0","article-title":"Is primary open-angle glaucoma a risk factor for diabetic retinopathy?","volume":"40","author":"Abikoye","year":"2020","journal-title":"Int Ophthalmol"},{"issue":"1","key":"10.1016\/j.survophthal.2026.06.009_bib251","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/s13098-025-01652-5","article-title":"The causal effect of glaucoma and diabetic retinopathy: a Mendelian randomization study","volume":"17","author":"Chen","year":"2025","journal-title":"Diabetol Metab Syndr"},{"issue":"4","key":"10.1016\/j.survophthal.2026.06.009_bib252","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1111\/aos.15300","article-title":"Bidirectional 5-year risks of diabetic retinopathy, glaucoma and\/or ocular hypertension: Results from a national screening programme","volume":"101","author":"Sperling","year":"2023","journal-title":"Acta Ophthalmol"},{"issue":"7","key":"10.1016\/j.survophthal.2026.06.009_bib253","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/j.ophtha.2024.01.016","article-title":"Association of Primary Open-Angle Glaucoma with Diabetic Retinopathy among Patients with Type 1 and Type 2 Diabetes: A Large Global Database Study","volume":"131","author":"Chauhan","year":"2024","journal-title":"Ophthalmology"},{"issue":"4","key":"10.1016\/j.survophthal.2026.06.009_bib254","doi-asserted-by":"crossref","first-page":"e252","DOI":"10.1111\/aos.12298","article-title":"Ocular perfusion pressure in glaucoma","volume":"92","author":"Costa","year":"2014","journal-title":"Acta Ophthalmol"},{"issue":"9","key":"10.1016\/j.survophthal.2026.06.009_bib255","doi-asserted-by":"crossref","DOI":"10.3390\/jcm9092829","article-title":"Retinal Neurovascular Coupling in Diabetes","volume":"9","author":"Garh\u00f6fer","year":"2020","journal-title":"J Clin Med"},{"issue":"4","key":"10.1016\/j.survophthal.2026.06.009_bib256","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1097\/00061198-200408000-00013","article-title":"Response of retinal vessel diameters to flicker stimulation in patients with early open angle glaucoma","volume":"13","author":"Garh\u00f6fer","year":"2004","journal-title":"J Glaucoma"},{"issue":"2","key":"10.1016\/j.survophthal.2026.06.009_bib257","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1097\/ICU.0b013e32831eef82","article-title":"Ocular perfusion pressure and glaucoma: Clinical trial and epidemiologic findings","volume":"20","author":"Leske","year":"2009","journal-title":"Curr Opin Ophthalmol"},{"issue":"1","key":"10.1016\/j.survophthal.2026.06.009_bib258","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.exer.2010.04.002","article-title":"Mechanisms of retinal ganglion cell injury and defense in glaucoma","volume":"91","author":"Qu","year":"2010","journal-title":"Exp Eye Res"},{"issue":"8","key":"10.1016\/j.survophthal.2026.06.009_bib259","doi-asserted-by":"crossref","first-page":"2176","DOI":"10.2337\/db07-1495","article-title":"Heritability of Proliferative Diabetic Retinopathy","volume":"57","author":"Hietala","year":"2008","journal-title":"Diabetes"},{"key":"10.1016\/j.survophthal.2026.06.009_bib260","doi-asserted-by":"crossref","DOI":"10.1155\/2010\/861291","article-title":"Identification of Diabetic Retinopathy Genes through a Genome-Wide Association Study among Mexican-Americans from Starr County, Texas","volume":"2010","author":"Fu","year":"2010","journal-title":"J Ophthalmol"},{"issue":"12","key":"10.1016\/j.survophthal.2026.06.009_bib261","doi-asserted-by":"crossref","first-page":"2472","DOI":"10.1093\/hmg\/ddr121","article-title":"Genome-wide meta-analysis for severe diabetic retinopathy","volume":"20","author":"Grassi","year":"2011","journal-title":"Hum Mol Genet"},{"issue":"2","key":"10.1016\/j.survophthal.2026.06.009_bib262","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/s00439-014-1517-2","article-title":"The association of previously reported polymorphisms for microvascular complications in a meta-analysis of diabetic retinopathy","volume":"134","author":"Hosseini","year":"2015","journal-title":"Hum Genet"},{"issue":"4","key":"10.1016\/j.survophthal.2026.06.009_bib263","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/j.ophtha.2010.07.020","article-title":"Genome-wide association study of diabetic retinopathy in a Taiwanese population","volume":"118","author":"Huang","year":"2011","journal-title":"Ophthalmology"},{"issue":"15","key":"10.1016\/j.survophthal.2026.06.009_bib264","doi-asserted-by":"crossref","first-page":"3165","DOI":"10.1093\/hmg\/ddt161","article-title":"Genome-wide association study in a Chinese population with diabetic retinopathy","volume":"22","author":"Sheu","year":"2013","journal-title":"Hum Mol Genet"},{"issue":"10","key":"10.1016\/j.survophthal.2026.06.009_bib265","doi-asserted-by":"crossref","first-page":"2288","DOI":"10.1007\/s00125-015-3697-2","article-title":"Genome-wide association study for sight-threatening diabetic retinopathy reveals association with genetic variation near the GRB2 gene","volume":"58","author":"Burdon","year":"2015","journal-title":"Diabetologia"},{"issue":"1","key":"10.1016\/j.survophthal.2026.06.009_bib266","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/s12881-018-0587-8","article-title":"Genome-wide association studies for diabetic macular edema and proliferative diabetic retinopathy","volume":"19","author":"Graham","year":"2018","journal-title":"BMC Med Genet"},{"key":"10.1016\/j.survophthal.2026.06.009_bib267","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1038\/s41525-019-0094-7","article-title":"Genome-wide association study for proliferative diabetic retinopathy in Africans","volume":"4","author":"Liu","year":"2019","journal-title":"NPJ Genom Med"},{"issue":"6","key":"10.1016\/j.survophthal.2026.06.009_bib268","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/S0002-9394(02)02291-2","article-title":"Relationship between human leukocyte antigen status and proliferative diabetic retinopathy in patients with younger-onset type 1 diabetes mellitus","volume":"135","author":"Mimura","year":"2003","journal-title":"Am J Ophthalmol"},{"issue":"4","key":"10.1016\/j.survophthal.2026.06.009_bib269","doi-asserted-by":"crossref","DOI":"10.1016\/j.xops.2024.100497","article-title":"An Epigenome-Wide Association Study of DNA Methylation and Proliferative Retinopathy over 28 Years in Type 1 Diabetes","volume":"4","author":"Miller","year":"2024","journal-title":"Ophthalmol Sci"},{"issue":"3","key":"10.1016\/j.survophthal.2026.06.009_bib270","doi-asserted-by":"crossref","first-page":"556","DOI":"10.2337\/dc11-1909","article-title":"Global Prevalence and Major Risk Factors of Diabetic Retinopathy","volume":"35","author":"Yau","year":"2012","journal-title":"Diabetes Care"},{"issue":"4","key":"10.1016\/j.survophthal.2026.06.009_bib271","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0198979","article-title":"Systematic review on barriers and enablers for access to diabetic retinopathy screening services in different income settings","volume":"14","author":"Piyasena","year":"2019","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.survophthal.2026.06.009_bib272","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s12916-025-04559-0","article-title":"Association between socioeconomic status and diabetic retinopathy in individuals with type 1 diabetes: a systematic review and meta-analysis","volume":"24","author":"Sebastian-Valles","year":"2025","journal-title":"BMC Med"},{"issue":"9","key":"10.1016\/j.survophthal.2026.06.009_bib273","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1167\/tvst.12.9.8","article-title":"Risk Factors and Outcomes of Delayed Presentation of Diabetic Retinopathy Patients to a County Hospital","volume":"12","author":"Lu","year":"2023","journal-title":"Transl Vision Sci & Technol"},{"issue":"8","key":"10.1016\/j.survophthal.2026.06.009_bib274","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1136\/bjo.2008.139568","article-title":"Initial experience with the Pascal photocoagulator: a pilot study of 75 procedures","volume":"92","author":"Sanghvi","year":"2008","journal-title":"Br J Ophthalmol"},{"issue":"3","key":"10.1016\/j.survophthal.2026.06.009_bib275","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1097\/00006982-198200230-00007","article-title":"Panretinal photocoagulation and retinal oxygenation","volume":"2","author":"Landers","year":"1982","journal-title":"Retina"},{"key":"10.1016\/j.survophthal.2026.06.009_bib276","first-page":"307","article-title":"Increased retinal oxygen supply following pan-retinal photocoagulation and vitrectomy and lensectomy","volume":"79","author":"Stefansson","year":"1981","journal-title":"Trans Am Ophthalmol Soc"},{"issue":"1","key":"10.1016\/j.survophthal.2026.06.009_bib277","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1080\/08820538.2017.1353820","article-title":"Panretinal Photocoagulation: A Review of Complications","volume":"33","author":"Reddy","year":"2018","journal-title":"Semin Ophthalmol"},{"issue":"9","key":"10.1016\/j.survophthal.2026.06.009_bib278","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1016\/j.ophtha.2018.02.034","article-title":"Loss to Follow-Up in Patients with Proliferative Diabetic Retinopathy after Panretinal Photocoagulation or Intravitreal Anti-VEGF Injections","volume":"125","author":"Obeid","year":"2018","journal-title":"Ophthalmology"},{"issue":"12","key":"10.1016\/j.survophthal.2026.06.009_bib279","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1016\/j.oret.2019.07.011","article-title":"Intravitreal Aflibercept for Retinal Nonperfusion in Proliferative Diabetic Retinopathy: Outcomes from the Randomized RECOVERY Trial","volume":"3","author":"Wykoff","year":"2019","journal-title":"Ophthalmol Retin"},{"issue":"2","key":"10.1016\/j.survophthal.2026.06.009_bib280","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1038\/s41433-021-01649-0","article-title":"Retinal non-perfusion in diabetic retinopathy","volume":"36","author":"Wykoff","year":"2022","journal-title":"Eye (Lond)"},{"issue":"1","key":"10.1016\/j.survophthal.2026.06.009_bib281","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.ophtha.2018.08.001","article-title":"Rationale and Application of the Protocol S Anti-Vascular Endothelial Growth Factor Algorithm for Proliferative Diabetic Retinopathy","volume":"126","author":"Sun","year":"2019","journal-title":"Ophthalmology"},{"issue":"3","key":"10.1016\/j.survophthal.2026.06.009_bib282","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.ophtha.2018.07.027","article-title":"Outcomes of Eyes Lost to Follow-up with Proliferative Diabetic Retinopathy That Received Panretinal Photocoagulation versus Intravitreal Anti-Vascular Endothelial Growth Factor","volume":"126","author":"Obeid","year":"2019","journal-title":"Ophthalmology"},{"issue":"23","key":"10.1016\/j.survophthal.2026.06.009_bib283","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/NHYK3694","article-title":"A systematic review of the cost-effectiveness of anti-VEGF drugs for the treatment of diabetic retinopathy","volume":"29","author":"Hodgson","year":"2025","journal-title":"Health Technol Assess"},{"issue":"11","key":"10.1016\/j.survophthal.2026.06.009_bib284","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1001\/archopht.1985.01050110038020","article-title":"Early vitrectomy for severe vitreous hemorrhage in diabetic retinopathy. Two-year results of a randomized trial. Diabetic Retinopathy Vitrectomy Study report 2","volume":"103","author":"The Diabetic Retinopathy Vitrectomy Study Research Group.","year":"1985","journal-title":"Arch Ophthalmol"},{"issue":"8","key":"10.1016\/j.survophthal.2026.06.009_bib285","first-page":"3718","article-title":"Clinical features and surgical outcomes of small-gauge vitrectomy in young adults with proliferative diabetic retinopathy: A comparison with 20-gauge vitrectomy ten years ago","volume":"64","author":"Aichi","year":"2023","journal-title":"Invest Ophthalmol & Vis Sci"},{"issue":"1","key":"10.1016\/j.survophthal.2026.06.009_bib286","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1159\/000530231","article-title":"A Systematic Review and Meta-Analysis of Clinical Outcomes of Small Gauge Vitrectomy with or without Intravitreal Anti-Vascular Endothelial Growth Factor Agents Pretreatment for Proliferative Diabetic Retinopathy","volume":"66","author":"Pei","year":"2023","journal-title":"Ophthalmic Res"},{"issue":"6","key":"10.1016\/j.survophthal.2026.06.009_bib287","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1038\/s41433-019-0739-x","article-title":"The role of steroids in treating diabetic macular oedema in the era of anti-VEGF","volume":"34","author":"Weinberg","year":"2020","journal-title":"Eye"},{"issue":"4","key":"10.1016\/j.survophthal.2026.06.009_bib288","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1159\/000499540","article-title":"A. The Role of Steroids in the Management of Diabetic Macular Edema","volume":"62","author":"Iglicki","year":"2019","journal-title":"Ophthalmic Res"},{"issue":"6","key":"10.1016\/j.survophthal.2026.06.009_bib289","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1007\/s00592-018-1117-z","article-title":"Progression of diabetic retinopathy severity after treatment with dexamethasone implant: a 24-month cohort study the 'DR-Pro-DEX Study","volume":"55","author":"Iglicki","year":"2018","journal-title":"Acta Diabetol"},{"issue":"8","key":"10.1016\/j.survophthal.2026.06.009_bib290","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1007\/s00592-018-1151-x","article-title":"Shall we stay, or shall we switch? Continued anti-VEGF therapy versus early switch to dexamethasone implant in refractory diabetic macular edema","volume":"55","author":"Busch","year":"2018","journal-title":"Acta Diabetol"},{"issue":"4","key":"10.1016\/j.survophthal.2026.06.009_bib291","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1089\/jop.2013.0104","article-title":"Anterior retinal cryotherapy and intravitreal injection of bevacizumab in the treatment of nonclearing vitreous hemorrhage in proliferative diabetic retinopathy","volume":"30","author":"Hsieh","year":"2014","journal-title":"J Ocul Pharmacol Ther"},{"issue":"7","key":"10.1016\/j.survophthal.2026.06.009_bib292","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1001\/archopht.1979.01020020018004","article-title":"Spencer R. Cryopexy treatment of proliferative diabetic retinopathy. Retinal cryoablation in patients with severe vitreous hemorrhage","volume":"97","author":"Schimek","year":"1979","journal-title":"Arch Ophthalmol"},{"issue":"12","key":"10.1016\/j.survophthal.2026.06.009_bib293","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1016\/j.ophtha.2005.07.010","article-title":"Cryotherapy of the anterior retina and sclerotomy sites in diabetic vitrectomy to prevent recurrent vitreous hemorrhage: an ultrasound biomicroscopy study","volume":"112","author":"Yeh","year":"2005","journal-title":"Ophthalmology"},{"issue":"6","key":"10.1016\/j.survophthal.2026.06.009_bib294","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/S0161-6420(87)33408-6","article-title":"Transconjunctival anterior retinal cryotherapy for proliferative diabetic retinopathy","volume":"94","author":"Benedett","year":"1987","journal-title":"Ophthalmology"},{"issue":"4","key":"10.1016\/j.survophthal.2026.06.009_bib295","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1001\/archopht.1990.01070060143065","article-title":"Clearance of Experimental Vitreous Hemorrhage After Panretinal Cryotherapy Is Related to Macrophage Influx","volume":"108","author":"Williams","year":"1990","journal-title":"Arch Ophthalmol"},{"issue":"6","key":"10.1016\/j.survophthal.2026.06.009_bib296","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1136\/bjo.72.6.401","article-title":"Panretinal cryotherapy in neovascular disease","volume":"72","author":"Vernon","year":"1988","journal-title":"Br J Ophthalmol"},{"issue":"1","key":"10.1016\/j.survophthal.2026.06.009_bib297","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1186\/s13098-022-00892-z","article-title":"A prediction model for worsening diabetic retinopathy after panretinal photocoagulation","volume":"14","author":"Li","year":"2022","journal-title":"Diabetol & Metab Syndr"},{"issue":"1","key":"10.1016\/j.survophthal.2026.06.009_bib298","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s10792-007-9106-1","article-title":"Vitreous hemorrhage in diabetic eyes previously treated with panretinal photocoagulation","volume":"28","author":"Kleinmann","year":"2008","journal-title":"Int Ophthalmol"},{"issue":"1","key":"10.1016\/j.survophthal.2026.06.009_bib299","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.ajo.2011.05.035","article-title":"Panretinal Photocoagulation for Proliferative Diabetic Retinopathy: Pattern Scan Laser Versus Argon Laser","volume":"153","author":"Chappelow","year":"2012","journal-title":"Am J Ophthalmol"},{"issue":"5","key":"10.1016\/j.survophthal.2026.06.009_bib300","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1001\/archophthalmol.2010.60","article-title":"Single-Session vs Multiple-Session Pattern Scanning Laser Panretinal Photocoagulation in Proliferative Diabetic Retinopathy: The Manchester Pascal Study","volume":"128","author":"Muqit","year":"2010","journal-title":"Arch Ophthalmol"},{"issue":"7","key":"10.1016\/j.survophthal.2026.06.009_bib301","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0219282","article-title":"Single session of pattern scanning laser versus multiple sessions of conventional laser for panretinal photocoagulation in diabetic retinopathy: Efficacy, safety and painfulness","volume":"14","author":"Nemcansky","year":"2019","journal-title":"PLOS ONE"},{"issue":"1","key":"10.1016\/j.survophthal.2026.06.009_bib302","doi-asserted-by":"crossref","DOI":"10.1136\/bmjophth-2020-000661","article-title":"Retinal arteriolar calibre and venular fractal dimension predict progression of proliferative diabetic retinopathy 6 months after panretinal photocoagulation: a prospective, clinical interventional study","volume":"6","author":"Torp","year":"2021","journal-title":"BMJ Open Ophthalmol"},{"issue":"9","key":"10.1016\/j.survophthal.2026.06.009_bib303","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1007\/s00417-016-3275-4","article-title":"Prediction of regression of retinal neovascularisation after panretinal photocoagulation for proliferative diabetic retinopathy","volume":"254","author":"Chatziralli","year":"2016","journal-title":"Graefe's Arch Clin Exp Ophthalmol"},{"issue":"6","key":"10.1016\/j.survophthal.2026.06.009_bib304","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1016\/j.survophthal.2021.03.001","article-title":"Anti-VEGF crunch syndrome in proliferative diabetic retinopathy: A review","volume":"66","author":"Tan","year":"2021","journal-title":"Surv Ophthalmol"},{"issue":"2","key":"10.1016\/j.survophthal.2026.06.009_bib305","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1136\/bjo.2007.127142","article-title":"Tractional retinal detachment following intravitreal bevacizumab (Avastin) in patients with severe proliferative diabetic retinopathy","volume":"92","author":"Arevalo","year":"2008","journal-title":"Br J Ophthalmol"},{"issue":"1","key":"10.1016\/j.survophthal.2026.06.009_bib306","article-title":"Intravitreal Bevacizumab (Avastin) for Diabetic Retinopathy: The 2010 GLADAOF Lecture","volume":"2011","author":"Arevalo","year":"2011","journal-title":"J Ophthalmol"},{"issue":"5","key":"10.1016\/j.survophthal.2026.06.009_bib307","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/j.ophtha.2008.11.005","article-title":"Microincision vitrectomy surgery and intravitreal bevacizumab as a surgical adjunct to treat diabetic traction retinal detachment","volume":"116","author":"Oshima","year":"2009","journal-title":"Ophthalmology"},{"issue":"1","key":"10.1016\/j.survophthal.2026.06.009_bib308","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1097\/ICB.0b013e3181578dd8","article-title":"Tractional retinal detachment after intravitreal injection of bevacizumab in proliferative diabetic retinopathy","volume":"3","author":"Torres-Soriano","year":"2009","journal-title":"Retin Cases Brief Rep"},{"issue":"4","key":"10.1016\/j.survophthal.2026.06.009_bib309","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1136\/bjophthalmol-2011-301005","article-title":"A shift in the balance of vascular endothelial growth factor and connective tissue growth factor by bevacizumab causes the angiofibrotic switch in proliferative diabetic retinopathy","volume":"96","author":"Van Geest","year":"2012","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.survophthal.2026.06.009_bib310","doi-asserted-by":"crossref","DOI":"10.1177\/24741264251351545","article-title":"Risk Factors for Recurrent Vitreous Hemorrhage After 25-Gauge Pars Plana Vitrectomy in Patients With Proliferative Diabetic Retinopathy","author":"Bitra","year":"2025","journal-title":"J Vitreoretin Dis"},{"issue":"3","key":"10.1016\/j.survophthal.2026.06.009_bib311","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000036963","article-title":"Investigation of the recurrent vitreous hemorrhage risk factors after early 25G vitrectomy in diabetic vitreous hemorrhage","volume":"103","author":"Yilmaz","year":"2024","journal-title":"Medicine"},{"issue":"1","key":"10.1016\/j.survophthal.2026.06.009_bib312","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1186\/s12886-020-01688-3","article-title":"Characteristics and outcomes of vitrectomy for proliferative diabetic retinopathy in young versus senior patients","volume":"20","author":"Liao","year":"2020","journal-title":"BMC Ophthalmol"},{"issue":"1","key":"10.1016\/j.survophthal.2026.06.009_bib313","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-51411-6","article-title":"Risk Factors of Neovascular Glaucoma After 25-gauge Vitrectomy for Proliferative Diabetic Retinopathy with Vitreous Hemorrhage: A Retrospective Multicenter Study","volume":"9","author":"Takayama","year":"2019","journal-title":"Sci Rep"},{"issue":"5","key":"10.1016\/j.survophthal.2026.06.009_bib314","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1080\/09286580500227068","article-title":"Risk factors for postoperative hemorrhage after vitrectomy for diabetic retinopathy","volume":"12","author":"Soto-Pedre","year":"2005","journal-title":"Ophthalmic Epidemiol"},{"issue":"1","key":"10.1016\/j.survophthal.2026.06.009_bib315","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-024-73395-8","article-title":"Incidence and risk factor analysis of neovascular glaucoma following vitrectomy in patients with proliferative diabetic retinopathy","volume":"14","author":"Hwang","year":"2024","journal-title":"Sci Rep"},{"key":"10.1016\/j.survophthal.2026.06.009_bib316","doi-asserted-by":"crossref","DOI":"10.1038\/srep39301","article-title":"Sustained Elevation of Intraocular Pressure Associated with Intravitreal Administration of Anti-vascular Endothelial Growth Factor: A Systematic Review and Meta-Analysis","volume":"6","author":"Zhou","year":"2016","journal-title":"Sci Rep"},{"issue":"7","key":"10.1016\/j.survophthal.2026.06.009_bib317","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1038\/eye.2009.332","article-title":"Axial length and intraoperative posterior vitreous detachment as predictive factors for surgical outcomes of diabetic vitrectomy","volume":"24","author":"Song","year":"2010","journal-title":"Eye (Lond)"},{"issue":"4","key":"10.1016\/j.survophthal.2026.06.009_bib318","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.ajo.2012.11.004","article-title":"Postoperative Vitreous Hemorrhage After Diabetic 23-Gauge Pars Plana Vitrectomy","volume":"155","author":"Khuthaila","year":"2013","journal-title":"Am J Ophthalmol"},{"issue":"1","key":"10.1016\/j.survophthal.2026.06.009_bib319","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1186\/s40942-025-00758-2","article-title":"Combined phacoemulsification and vitrectomy for proliferative diabetic retinopathy: an increased risk of early recurrence but not long-term neovascular glaucoma","volume":"11","author":"Li","year":"2025","journal-title":"Int J Retin Vitr"},{"issue":"6","key":"10.1016\/j.survophthal.2026.06.009_bib320","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1097\/IAE.0000000000003453","article-title":"Posterior Vitreous Detachment Status as a Predictive Factor for Outcomes of Vitrectomy for Diabetic Vitreous Hemorrhage","volume":"42","author":"Tandias","year":"2022","journal-title":"Retina"},{"key":"10.1016\/j.survophthal.2026.06.009_bib321","first-page":"29","article-title":"Iatrogenic retinal breaks during 20-gauge vitrectomy for proliferative diabetic retinopathy","volume":"7","author":"Kamura","year":"2013","journal-title":"Clin Ophthalmol"},{"issue":"2","key":"10.1016\/j.survophthal.2026.06.009_bib322","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.survophthal.2010.08.003","article-title":"Advantages and Limitations of Small Gauge Vitrectomy","volume":"56","author":"Thompson","year":"2011","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/j.survophthal.2026.06.009_bib323","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/6764932","article-title":"Change of Vascular Endothelial Growth Factor Levels following Vitrectomy in Eyes with Proliferative Diabetic Retinopathy","volume":"2019","author":"Chen","year":"2019","journal-title":"J Ophthalmol"},{"issue":"4","key":"10.1016\/j.survophthal.2026.06.009_bib324","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1111\/ceo.14363","article-title":"Current understanding of subclinical diabetic retinopathy informed by histology and high-resolution in vivo imaging","volume":"52","author":"Hein","year":"2024","journal-title":"Clin Exp Ophthalmol"},{"issue":"1","key":"10.1016\/j.survophthal.2026.06.009_bib325","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/s40942-025-00670-9","article-title":"The efficacy of artificial intelligence in diabetic retinopathy screening: a systematic review and meta-analysis","volume":"11","author":"Alqahtani","year":"2025","journal-title":"Int J Retin Vitr"},{"issue":"10","key":"10.1016\/j.survophthal.2026.06.009_bib326","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.2337\/dci23-0032","article-title":"Artificial Intelligence and Diabetic Retinopathy: AI Framework, Prospective Studies, Head-to-head Validation, and Cost-effectiveness","volume":"46","author":"Rajesh","year":"2023","journal-title":"Diabetes Care"},{"issue":"1","key":"10.1016\/j.survophthal.2026.06.009_bib327","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1186\/s13287-022-03073-x","article-title":"Advances in cell therapies using stem cells\/progenitors as a novel approach for neurovascular repair of the diabetic retina","volume":"13","author":"Lechner","year":"2022","journal-title":"Stem Cell Res & Ther"},{"key":"10.1016\/j.survophthal.2026.06.009_bib328","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.3389\/fendo.2024.1416668","article-title":"Cell and molecular targeted therapies for diabetic retinopathy","volume":"15","author":"Reddy","year":"2024","journal-title":"Front Endocrinol"},{"issue":"10326","key":"10.1016\/j.survophthal.2026.06.009_bib329","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/S0140-6736(22)00018-6","article-title":"Efficacy, durability, and safety of intravitreal faricimab with extended dosing up to every 16 weeks in patients with diabetic macular oedema (YOSEMITE and RHINE): two randomised, double-masked, phase 3 trials","volume":"399","author":"Wykoff","year":"2022","journal-title":"Lancet"},{"issue":"7","key":"10.1016\/j.survophthal.2026.06.009_bib330","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0002675","article-title":"The angio-fibrotic switch of VEGF and CTGF in proliferative diabetic retinopathy","volume":"3","author":"Kuiper","year":"2008","journal-title":"PLoS One"},{"issue":"12","key":"10.1016\/j.survophthal.2026.06.009_bib331","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1038\/70963","article-title":"Regulation of vascular endothelial growth factor-dependent retinal neovascularization by insulin-like growth factor-1 receptor","volume":"5","author":"Smith","year":"1999","journal-title":"Nat Med"},{"issue":"1","key":"10.1016\/j.survophthal.2026.06.009_bib332","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1177\/1758834011422556","article-title":"An overview of the c-MET signaling pathway","volume":"3","author":"Organ","year":"2011","journal-title":"Ther Adv Med Oncol"},{"issue":"7","key":"10.1016\/j.survophthal.2026.06.009_bib333","first-page":"1885","article-title":"Mechanisms of Hepatocyte Growth Factor\u2013Induced Retinal Endothelial Cell Migration and Growth","volume":"41","author":"Cai","year":"2000","journal-title":"Invest Ophthalmol & Vis Sci"},{"issue":"2","key":"10.1016\/j.survophthal.2026.06.009_bib334","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1167\/iovs.61.2.26","article-title":"Correlation of Aqueous, Vitreous, and Plasma Cytokine Levels in Patients With Proliferative Diabetic Retinopathy","volume":"61","author":"Wu","year":"2020","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"8","key":"10.1016\/j.survophthal.2026.06.009_bib335","doi-asserted-by":"crossref","first-page":"5471","DOI":"10.1167\/iovs.13-12212","article-title":"Inflammatory biomarkers and progression of diabetic retinopathy in African Americans with type 1 diabetes","volume":"54","author":"Roy","year":"2013","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.survophthal.2026.06.009_bib336","article-title":"Correlations Between Different Angiogenic and Inflammatory Factors in Vitreous Fluid of Eyes With Proliferative Diabetic Retinopathy","volume":"8","author":"Wu","year":"2021","journal-title":"Front Med (Lausanne)"},{"issue":"3","key":"10.1016\/j.survophthal.2026.06.009_bib337","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1007\/s10384-011-0004-8","article-title":"Expression profiles of cytokines and chemokines in vitreous fluid in diabetic retinopathy and central retinal vein occlusion","volume":"55","author":"Suzuki","year":"2011","journal-title":"Jpn J Ophthalmol"},{"issue":"5","key":"10.1016\/j.survophthal.2026.06.009_bib338","doi-asserted-by":"crossref","DOI":"10.3390\/cells10051069","article-title":"Cytokine Levels in Human Vitreous in Proliferative Diabetic Retinopathy","volume":"10","author":"Loporchio","year":"2021","journal-title":"Cells"},{"issue":"12","key":"10.1016\/j.survophthal.2026.06.009_bib339","doi-asserted-by":"crossref","first-page":"2203","DOI":"10.1007\/s001250100030","article-title":"Risk factors for progression to proliferative diabetic retinopathy in the EURODIAB Prospective Complications Study","volume":"44","author":"Porta","year":"2001","journal-title":"Diabetologia"},{"issue":"6","key":"10.1016\/j.survophthal.2026.06.009_bib340","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0127188","article-title":"Prevalence and Cardiovascular Associations of Diabetic Retinopathy and Maculopathy: Results from the Gutenberg Health Study","volume":"10","author":"Raum","year":"2015","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.survophthal.2026.06.009_bib341","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.2337\/dc12-0790","article-title":"Predicting development of proliferative diabetic retinopathy","volume":"36","author":"Harris Nwanyanwu","year":"2013","journal-title":"Diabetes Care"}],"container-title":["Survey of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039625726000846?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039625726000846?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T20:06:55Z","timestamp":1789070815000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0039625726000846"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":341,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["S0039625726000846"],"URL":"https:\/\/doi.org\/10.1016\/j.survophthal.2026.06.009","relation":{},"ISSN":["0039-6257"],"issn-type":[{"value":"0039-6257","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Predicting the progression of proliferative diabetic retinopathy: Pathophysiology, imaging phenotypes, and determinants of disease persistence despite therapy","name":"articletitle","label":"Article Title"},{"value":"Survey of Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.survophthal.2026.06.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}